Discovering Disease Associated Gene-Gene Interactions: A Two SNP Interaction Analysis Framework by Antoniades, A.
  
 
 
 
 
 
DISCOVERING DISEASE 
ASSOCIATED GENE-GENE 
INTERACTIONS: A TWO SNP 
INTERACTION ANALYSIS 
FRAMEWORK  
 
 
Athos Antoniades 
University of Cyprus   
20 May 2011 
  
2 
 
 
 
DISCOVERING DISEASE 
ASSOCIATED GENE-GENE 
INTERACTIONS: A TWO SNP 
INTERACTION ANALYSIS 
FRAMEWORK  
 
Athos Antoniades 
 
 
A dissertation 
Submitted in Partial Fulfilment of the 
Requirements for the Degree of 
Doctor of Philosophy 
at the University of Cyprus 
 
 
 
Recommended for Acceptance 
By the Department of Computer Science 
May, 2011 
  
3 
 
 
 
 
 
 
© Copyright by 
Athos Antoniades 
 
 
 
 
 
 
 
All Rights Reserved 
 
 
 
 
2011 
  
4 
 
 
 
 
 
  
5 
 
ACKNOWLEGMENTS 
I gratefully acknowledge the contributions of all those who helped me complete this PhD 
thesis dissertation. First and foremost, I thank my dissertation supervisor; Dr.Constantinos 
Pattichis who guided me for the duration of my study helping me grow as a PhD student and a 
person with his insightful advice, critique and guidance.  
I would also like to thank Dr. Lefkos Midletton who introduced me to the problem of two 
SNP interaction testing and who has helped me as a mentor advance my career as a computer 
scientist in the pharmaceutical industry in a way that enabled me to gain the necessary 
background information to achieve my goals.  
I also thank my committee members, Dr. Christos Christodoulou, Dr. Pedro Trancoso, Dr. 
Vasilis Promponas and Dr. Dimitris Koutsouris who helped me ensure rigor in the qualitative 
part of my study and improve the technical writing aspects of my dissertation.  
Moreover, I thank my colleagues, Dr. Paul Matthews and Dr. Nicholas Galwey, who have 
provided me with their knowledge and support in researching, developing and evaluating the 
proposed framework derived from my PhD work. 
Finally, I thank my wife, Dr. Iolie Nicolaidou, my daughter Nefeli Antoniades and my parents 
Antonis and Aggeliki Antoniades for their continued support over the years. 
 
  
6 
 
CREDITS 
 
This work was partly funded by Glaxo Smith Kline through agreement COL27381.  
7 
 
Table of Contents 
CHAPTER 1 INTRODUCTION 14 
1.1 Problem statement 16 
1.1.1 Data encoding 16 
1.1.2 Measure of epistasis 17 
1.1.3 Computing multidimensional contingency tables 18 
1.1.4 Multiple testing problem 19 
1.1.5 Computational complexity and high performance computing 20 
1.2 Original contributions 21 
1.2.1 Data encoding 21 
1.2.2 Measure of epistasis 22 
1.2.3 Computing multidimensional contingency tables 22 
1.2.4 Evaluation of significance through replication 23 
1.2.5 Hybrid cluster cloud high performance computing (HCC-HPC) framework 24 
1.3 Structure of this dissertation 25 
CHAPTER 2 BACKGROUND KNOWLEDGE 26 
2.1 Molecular biology and medical genetics 26 
2.1.1 Macromolecules DNA, mRNA and proteins 28 
2.1.2 SNPs 28 
2.1.3 Genes 30 
2.1.4 Linkage disequilibrium 31 
2.1.5 Complex versus Mendelian diseases 34 
2.1.6 Genetic and environmental factors 34 
2.2 Statistical genetics 35 
2.2.1 Response - explanatory variables terminology in genetics 35 
2.2.2 Regression analysis 36 
2.2.3 Testing the null hypothesis 37 
2.2.4 Statistical significance and multiple testing problem 38 
2.2.5 Main effect 40 
2.2.6 Epistasis 40 
CHAPTER 3 LITERATURE REVIEW 42 
3.1 Data encoding 42 
3.1.1 The MERLIN format 43 
3.1.2 PLINK’s Method for binary ped files 45 
3.2 Measures of epistasis 47 
3.2.1 Logistic regression 51 
3.2.2 Odds ratio multiplicative interaction measure 51 
8 
 
3.2.3 Case only analysis with chi-square 52 
3.3 Computing multidimensional contingency tables 54 
3.3.1 The classical data driven approach 54 
3.3.2 The random walk approach, monte carlo sampling 55 
3.4 Evaluation of significance through replication 56 
3.4.1 Combine GWAS and repeat analyses 57 
3.4.2 Examine the distribution of effects across the genotype combinations 57 
3.5 Analytical frameworks for gene-gene interaction testing using GWAS data 58 
3.5.1 Two SNP interaction testing using HPC 59 
3.5.1.1 Cluster HPC 59 
3.5.1.2 GBOOST: a GPU-based tool for detecting gene-gene interactions in genome-wide case 
control studies 60 
3.5.2 Data mining methods 62 
3.5.2.1 Recursive partitioning 62 
3.5.2.2 Recursive partitioning with ensemble of trees (forest) 65 
3.5.2.3 Multifactor dimensionality reduction 66 
3.5.3 Filtering approaches 67 
CHAPTER 4 TWO SNP INTERACTION FRAMEWORK 70 
4.1 Functional requirements 70 
4.2 Data encoding 71 
4.3 Measure of epistasis 75 
4.3.1 The proposed measure 77 
4.3.2 The logistic regression model used as a test statistic 83 
4.4 Computation of multiple response variables 84 
4.5 Evaluation of significance through replication 87 
4.6 Hybrid Cluster Cloud High Performance Computing (HCC-HPC) 88 
4.6.1 Dedicated LAN grid 88 
4.6.2 WAN grid 89 
4.6.3 Benchmarking of existing HPC resources 91 
4.6.4 HCC-HPC proposed framework 92 
4.7 The proposed framework put together 100 
4.7.1 The analyses on the HCC-HPC 100 
4.7.2 Post processing results 101 
4.7.3 Replication test 101 
CHAPTER 5 RESULTS 103 
5.1 Datasets used for the evaluation of the proposed framework 103 
5.1.1 Primary dataset (GeneMSA) 104 
9 
 
5.1.2 Replication dataset (ANZgene) 104 
5.1.3 Addressing incomplete genetic marker overlap between primary and replication dataset 105 
5.2 Biological Results 106 
5.3 Data Encoding 121 
5.4 Measure of epistasis 123 
5.6 Computation of multiple response variables 128 
5.7 Evaluation of significance through replication 129 
5.8 Hybrid cluster cloud high performance computing (HCC-HPC) 133 
CHAPTER 6 DISCUSSION 139 
6.1 Biological Results 139 
6.2 Data Encoding 142 
6.2.1 Information Loss 142 
6.2.2 Added Information Capability 142 
6.2.3 Size of encoded data 143 
6.3 Measure of epistasis 143 
6.4 Computation of multiple response variables 146 
6.5 Evaluation of significance through replication 147 
6.6 Hybrid cluster cloud - high performance computing (HCC-HPC) 149 
6.6.1 Performance of WAN grid alone 149 
6.6.2 Performance of dedicated LAN 149 
6.6.3 Performance of the HCC-HPC proposed platform 150 
6.7 The proposed framework versus other gene-gene interaction testing methodologies 151 
6.8 Potential pharmaco-genetic impact of the proposed framework 153 
CHAPTER 7 CONCLUSIONS AND FUTURE WORK 156 
7.1 Conclusions 156 
7.2 Future Work 159 
7.2.1 Measure of epistasis for n SNPs 159 
7.2.2 Distributed Neural Network (NN) approach for subject cluster discovery 160 
7.2.3 Gene-gene interaction testing in a box 161 
  
10 
 
LIST OF TABLES 
Table 1 A sample Merlin format pedigree file 44 
Table 2 PLINK binary format data encoding [13,52] 46 
Table 3 Comparison of existing measures of epistasis using statistical or data mining approaches 50 
Table 4 Reported time comparisons between PLINK BOOST and GBOOST 61 
Table 5 Two SNP interaction testing frameworks 69 
Table 6 Proposed allelic Encoding 74 
Table 7 Proposed SNP genotype encoding 74 
Table 8 Contingency table for a single SNP 75 
Table 9 Contingency table for two SNPs (2d representation) and response variable disease status 76 
Table 10 Contingency table with totals estimated 82 
Table 11 Table of expected values (E) with formulas for estimating it’s cell values from the observed 
table (O)(Table 10) 82 
Table 12 GeneMSA dataset description from [80] 115 
Table 13 Distribution of Subjects in GeneMSA 115 
Table 14 Distribution of Subjects in ANZgene 116 
Table 15 Results of MS cases vs controls in primary and replication datasets. 117 
Table 16 Results of Data Compression 122 
Table 17 Performance of proposed contingency multidimensional contingency table computing 
algorithm 128 
Table 18 Experimental and estimated runtime on each HPC and proposed framework. 138 
Table 19 Comparison proposed versus existing measures of epistasis using statistical or data mining 
approaches 145 
Table 20 Two SNP interaction testing frameworks and the proposed method 155 
 
 
  
11 
 
LIST OF FIGURES 
Figure 1 From DNA to proteins, the biological mechanism 27 
Figure 2 A SNP on DNA strands 29 
Figure 3 Linkage disequilibrium map example 33 
Figure 4 Computing contingency tables, the traditional approach 55 
Figure 5 Recursive partitioning approach example 64 
Figure 6 Contingency table for two SNPs (3d representation) and response variable disease status 76 
Figure 7 Pseudo code for Pearson's chi-square test with Yates correction for continuity 81 
Figure 8 Pseudo code of omnibus and epistasis test function 81 
Figure 9 Contingency tables for two SNPs  and multiple response variables(4d representation) 85 
Figure 10 Pseudo code of the 4-dimensional algorithm for generating multiple contingency tables on 
a single pass from the database. 86 
Figure 11 Architecture of the dedicated LAN grid 89 
Figure 12 Architecture of the WAN grid 90 
Figure 13 The structure of the purposed built HCC-HPC proposed system 93 
Figure 14 A high level view of HCC-HPC algorithmic steps 95 
Figure 15 Pseudo code of selection algorithm for PC to use for running a worknode 97 
Figure 16 Pseudo code of algorithm followed by the WAN grid agent on each node 98 
Figure 17 Pseudo code of WAN grid handling of worknode state reporting 99 
Figure 18 Pseudo code of the LAN grid algorithmic steps 100 
Figure 19 Top Epistasis results of complete GenMSA case-control analyses. A strong peak is visible 
were both markers are on chromosome 6 in the HLA region some passing statistical 
significance after multiple testing correction 109 
Figure 20 Epistasis vs Omnibus measures of the top Epistasis results in the complete GenMSA case-
control analyses 110 
Figure 21 Epistasis vs Omnibus measures in ANZgene on the results tested for replication. 111 
Figure 22 Epistasis vs Omnibus measures of the top Epistasis results in the analysis of only males in 
GenMSA 112 
Figure 23 Epistasis vs Omnibus measures of the top Epistasis results in the analysis of only females 
in GenMSA 113 
Figure 24 Zoom in of region with high replicated interaction frequency 114 
Figure 25 Main effect comparison between logistic regression (y-axis) and Pearson’s chi-square test 
with Yates correction for continuity (x-axis). 125 
Figure 26 Comparison between the omnibus measures produced using the Pearson’s chi-square test 
with Yates correction and the logistic regression model fitting test. 126 
Figure 27 Comparison between the Epistasis measures produced using the Pearson’s chi-square test 
with Yates correction and the logistic regression model fitting test. 127 
Figure 28 Replication test for correlation of distribution of effects on genotype combinations 
between the two diseases 131 
Figure 29 Bar chart of the chi-square metric per genotype in the two datasets signed for phenotype 
predisposition direction at each column. 132 
Figure 30 Estimated runtime based on the number of tests for GWAS up to 3.1 million SNPs. 137 
Figure 31 PubMed search linking Human Leukocyte Antigen to multiple sclerosis where 1829 
publications were found 141 
Figure 32 Sample run of Neural Network for clustering subjects based on their genetic data at 
specific loci. 162 
  
12 
 
 LIST OF ACRONYMS 
CNV Copy Number Variation 
CPU Central Processing Unit 
CUDA Compute Unified Device Architecture 
DNA Deoxyribo-Nucleic Acid 
GWAS Genome Wide Association Scans 
HCC-HPC Hybrid Cluster Cloud High Performance Computing 
HLA Human Leukocyte Antigen  
HPC High Performance Computing 
LAN Local Area Network 
LDL Low Density Lipoprotein 
MDR Mutlti-Dimensionality Reduction 
MS Multiple Sclerosis 
SNP Single Nucleotide Polymorphisms 
WAN Wide Area Network 
 
 
  
13 
 
Abstract 
Most common diseases have a heritable component that is influenced by mutations on 
multiple loci, and by interactions between loci and with the environment. However, 
traditional genetic analysis techniques have focused on single locus effects. This is 
mostly due to the polynomial increase in computational capacity needed to attempt 
multi-loci interaction analyses, and the anticipated loss of power due to multiple 
testing. In this dissertation, a framework for performing a complete two single 
nucleotide polymorphism (SNP) interaction analysis of high dimensionality genome 
wide association scans (GWAS) is presented. The implementation of the framework 
utilizes diverse distributed computational resources to overcome the bottlenecks of 
each resource, harvesting enough capacity to analyze any of the GWAS in existence 
today within a reasonable time frame. Algorithmic approaches are proposed to 
improve the efficiency of the framework and improve its computational performance 
so that a brute force attack on the problem can be performed. The data is encoded in 
binary using a lossless algorithm that significantly reduces its size. Computationally 
efficient data mining measures for the Omnibus and Epistatic interaction effects are 
proposed and compared to traditional statistical techniques. An algorithm is proposed 
that optimizes the analyses of multiple response variables within the same GWAS. 
GenMSA, a multiple sclerosis (MS) dataset, is analyzed using the proposed 
framework with top results tested for replication using ANZgene, an independent MS, 
dataset. Some of the top results replicated, implicating SNPs in a region of known 
association to MS providing evidence to the validity of the proposed framework. Top 
results are further examined through a proposed approach that enables drilling into 
these results and studying correlation coefficient between each of the genotype 
combinations of the SNP and the signal level to each of the main and epistatic effects.   
14 
 
Chapter 1  Introduction 
Most common diseases that have a heritable component such as diabetes, multiple 
sclerosis, schizophrenia and dyslipidemia are influenced by mutations on multiple 
loci, interactions between loci and interactions with the environment. In genetic 
studies, due to limitations in genotyping technology, traditionally only a small subset 
of the genome could be analyzed, so candidate gene studies were common. The 
introduction of affordable high throughput genotyping technologies (DNA chips) 
allows the assay of more than half a million single nucleotide polymorphisms (SNPs) 
per subject across the whole genome. Genetic association studies applying such 
technology allow investigation of the vast majority of common loci variants in the 
human genome; such studies are typically called genome wide association scans 
(GWAS). These GWAS provide an unprecedented opportunity to identify genetic 
variations associated with diseases. 
However, traditional analyses techniques have focused on discovering single locus 
effects rather than multi-loci effects in GWAS studies. This approach has yielded 
rather limiting results in many studies because the model used is too simple and is 
being applied in a complex reality. Commonly used arguments for this practice are the 
increased computational requirements and the loss of power of detection following 
correction for multiple testing in multi-loci analyses. In the few cases where multiple 
loci interactions have been examined, only a subset of the search space has been 
analyzed. Typically loci with no or very small main effects (little or no single-marker 
association to the phenotype) were not included even though there is no reason to 
believe that they could not be involved in a strong multi-locus interaction associated 
with a complex disease [1,2,3]. 
15 
 
Approaches that attempted to test for gene-gene interaction in GWAS data can be split 
into two categories, those that attempt to perform an exhaustive, or near exhaustive 
search, and those that attempt to use machine learning approaches derived from data 
mining to discover gene-gene interactions without going through the whole search 
space.  
Another key issue that arises from current research is the need to develop new 
statistical measures to quantify the epistatic effect. There is a common 
acknowledgement in the field that end results need to be statistically interpretable, 
with p-values as the statistic of choice (the probability of obtaining a test statistic at 
least as extreme as the one that was actually observed, assuming that the null 
hypothesis is true) [4,5,6].  However, the traditional analytical approaches to getting 
p-values for interactions are too slow to perform at the whole genome level. Therefore 
estimations have been proposed that attempt to provide close approximations to the 
actual statistic in a computationally efficient manner[2]. 
The evaluation of genetic results, and by extension the methods used to obtain them, 
are traditionally based on replication testing. Replication testing involves the use of 
two independent datasets to test if a hypothesis tested and found to be significant in 
one study replicated under the same parameters in a second independent study. A 
concise, replication methodology is necessary to be defined a-priory accompanied 
with a solid mathematical proof that the probability of reporting replicated results that 
are in reality false positive is extremely low.  
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1.1 Problem statement  
With the complete sequencing of the human genome one might expect a plethora of 
drug targets for many diseases to be discovered [7]. This however isn’t the case, since 
the analytical techniques applied to these data were focused on simple Mendelian 
diseases (diseases where a single genetic polymorphism was responsible for a 
phenotypical trait) while the majority of common diseases in humans are complex 
diseases (multiple genetic polymorphisms and environmental factors predispose a 
subject’s disease status) [8].  
The work presented in this thesis dissertation was focused around identifying the key 
problems surrounding the lack of a method performing a complete GWAS two SNP 
interaction test and addressing each one of them. Through this process several 
problems were identified, and each required an original contribution to be researched 
and developed in order for the proposed framework to get completed. In this section 
the key problems addressed in this dissertation are presented.  
1.1.1 Data encoding  
The need to reduce the size of the data is owed to the 100 fold increase in the 
genotyping capacity available today combined with the massive reduction in cost. 
Today’s technology has the ability to analyze datasets up to 550,000 or even 1 million 
SNPs per subject with >99% accuracy, at a rate of >100 K genotypes per day and at a 
cost of around 20–30 cents per genotype [9,10,11]. 
Traditionally, the genetic data in these studies is stored in the QTDT (Quantitative and 
Discrete Traits) format introduced in the program QTDT and MERLIN [12]. Input 
files describe relationships between individuals in a dataset, store marker genotypes, 
17 
 
disease status and quantitative traits and provide information on marker locations and 
allele frequencies.  
There was already a technique for compressing this data by utilizing a binary 
encoding PLINK [13]. However, that technique was focused at encoding SNPs as 
markers to be used in analyses that don’t require the information of which DNA strand 
each allele belongs to. Today as more GWAS datasets become available researchers 
are developing innovative new methodologies to analyze them. Some of these 
methodologies are not relying so much on the SNPs as markers; rather they look at the 
sequence of genotyped alleles on each strand of DNA separately. The methodology 
used in PLINK [13] to encode the data looses the information of which strand holds 
each allele’s genotype for heterozygote SNPs. This makes it impossible to run 
analyses that use strand information using the binary input format for GWAS.  
1.1.2 Measure of epistasis  
The established way of measuring epistasis with categorical response variables in 
genetic data is logistic regression [2,3,14]. However, logistic regression is not very 
fast and is therefore usually applied to test small subsets of the datasets. A faster 
computational approach is needed that will provide results comparable to logistic 
regression [2]. However the key aspects that make logistic regression the analysis of 
choice would need to be retained, such as testing for the null hypothesis generating p-
values. Furthermore, a key issue in analyzing genetic data is the non-independence of 
markers, an issue that exists with logistic regression; any proposed methodology 
would need to not provide a positive bias towards loci that are non-independent [3].   
The correlation between any proposed methodology and logistic regression is defined 
a-priory at 5% correlation between any proposed methodology and logistic regression 
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in order to accept it as producing sufficiently converging estimations to logistic 
regression.  
1.1.3 Computing multidimensional contingency tables  
In the majority of case-control studies with genetic data, more than one phenotype 
may be important even though the subject disease status (case - control) is typically 
the most interesting one. Many diseases tend to have different characteristics, or 
different distributions in sub-populations and typically, when performing genetic 
analyses, the goal is not only to identify genetic loci associated with the case-control 
status but also to identify the ones that are associated with subsets of subjects that 
exhibit other phenotypes (phenotypes are used as response variables) relative to the 
disease [4]. As an example, Multiple Sclerosis (MS) is more evident in females than 
males, it’s not clear if this is due to environmental or genetic factors [15]. It is 
therefore logical to ask if a reported association is driven by males, females or both. 
Similarly, most diseases including MS, have subtypes, and it’s typically interesting to 
test whether a specific effect is associated with one of the subtypes [11,16]. Such 
questions typically require a re-analysis of the dataset for each phenotype definition in 
order to perform data mining on each of the variables, and then collect all results 
together in a single table to interpret. However, traditional analyses also typically 
involve only univariate analysis that has a computational complexity of O = n, where 
n is the number of SNP’s while in a complete two SNP interaction test as attempted in 
this work the computational complexity is O(n
2
). To put this in perspective, a 
univariate analyses on a typical personal computer today will take a few minutes. A 
complete two SNP interaction analysis will take several months if not years. Having to 
repeat the analyses for every phenotype of interest in the case of the univariate 
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analysis does not increase the requirements to an unacceptable level. In the case of 
two SNP interactions, however, it multiplies the complexity of an already challenging 
task by a factor equal to the number of extra response variables to be tested. Counting 
the values for a contingency table and the sums of all rows and columns is a known P 
hard problem [17]. Furthermore, the research in finding solutions to the problem is 
focused on getting approximate counts of the table using heuristics [18,19]. However 
this would result in loss of information in the case of GWAS analysis, since the 
number of subjects are limited compared to the statistical power needed, thus any 
approach which sacrifices statistical power in order to provide a linear increase in 
performance should be avoided.  
1.1.4 Multiple testing problem  
The multiple testing problem is a major issue in GWAS analyses that needs to be 
addressed [20]. Multiple testing, or multiple comparisons as it’s sometimes referred to 
in statistics is a problem that occurs when a set of statistical inferences are considered 
simultaneously [20]. Errors in inference that fail to include their corresponding 
population parameters or hypothesis tests that incorrectly reject the null hypothesis are 
more likely to occur when one considers the set as a whole. The multiple testing 
problem is especially evident in data mining applications that test high dimensional 
datasets [21] such as the ones analyzed as part of this dissertation work. Traditionally, 
in genetic analyses heuristics such as the Bonferoni correction [22] were used to 
adjust for it [23]. Bonferoni correction is based on the idea that if an experiment is 
testing a dependent or independent hypothesis on a set of data, then one way of 
maintaining the set-wise error rate is to test each hypothesis at a statistical significance 
level of 1/n times of what it would be if only one hypothesis were tested, where n is 
20 
 
the number of tests performed. So if there is a need to compute the significance level 
of a set of tests n to be at most a, then the Bonferoni correction would be to test each 
of the individual tests at a significance level of (a/n) [24]. Statistical significance 
simply means that a given result is unlikely to have occurred by chance assuming the 
null hypothesis is actually correct (i.e. no effect) [25]. Bonferoni corrections tend to 
over-adjust, thus making identifying statistically significant p-values after correction 
for multiple testing a very difficult task [24,26]. Traditionally, the only test that was 
considered to be ideal for adjusting for multiple testing is replication testing [27]. 
The current norm in identifying a result as statistically significant or not is to a-priory 
set an arbitrary level of significance, up to which the results will be rejected as invalid 
[6]. In genetics, the typical level of statistical significance is either p<0.05 or p<0.01. 
This level of significance still involves a pretty high probability of error (5% or 1%) . 
Furthermore, the statistical measures used to estimate p, usually assume a normal 
distribution between the results and this only holds if the results are independent, but 
as it will be discussed in later sections in real life applications this assumption does 
not hold.  
1.1.5 Computational complexity and high performance 
computing  
The problem of testing for all two SNP interactions in GWAS has a growth rate of 
O=n
2 
where n is the number of SNPs to be analyzed. Since the typical GWAS contain 
hundreds of thousands of SNPs and some even have over a million SNPs it’s 
important to use a system capable of providing enough computational capacity both 
for current and for expected high dimensionality of GWAS. Therefore it’s expected 
that in order to address the computational requirements of performing a complete two 
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SNP interaction test in a high dimensional GWAS, a high performance computing 
resource is required. This problem requires large computational capacity as well as 
large data storage and transfer capacity between the nodes of a distributed system 
[1,8,28].  
1.2 Original contributions 
The main contribution of this thesis is the proposed framework for a complete two 
SNP interaction testing in high dimensional GWAS. In order to overcome the 
problems associated with designing and developing a two SNP interaction framework, 
several original contributions in the fields of data mining, high performance 
computing and statistical genetics were made and are presented in the next sections of 
this dissertation. 
1.2.1 Data encoding 
A proposed methodology is presented that enables encoding of the GWAS data in a 
way that results in a lossless compression of the data compared to the traditional 
“MERLIN” format [12]. Furthermore, even though this method results in twice as 
large files compared to a similar approach presented in [13], it does not suffer from a 
loss of information. Although this issue does not affect univariate analyses, 
multivariate analyses may be affected. Furthermore the proposed methodology 
enables encoding of deleted SNPs, a type of polymorphism that is gaining momentum 
in being detected and combined in some analytical techniques with traditional SNP 
data.  
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1.2.2 Measure of epistasis 
 A new measure of epistasis was proposed in order to test for the epistatic effect, a 
term used in Biology to identify the interaction effect between two loci. The 
advantage of the proposed measure is that it’s designed to be considerably faster than 
logistic regression, the established method of measuring epistasis, improving the 
efficiency of the proposed framework.  Through the algorithmic steps to estimate the 
interaction effect, an established omnibus measure is also calculated that represents 
the total association between the categorical variables and a response variable.  
To put this in data mining terms, the proposed methodology enables the evaluation of 
the probability that a multidimensional association rule is a false positive assuming the 
rule (null hypothesis) is true.  
1.2.3 Computing multidimensional contingency tables 
As a way to further improve the efficiency of the proposed framework, an algorithm 
that supports generating efficiently all contingency tables for each of the response 
variables to be tested is proposed. Assuming the number of response variables to be 
tested is φ, the proposed algorithm is nearly φ times faster than the traditional 
approach. The proposed algorithm succeeds this optimization by identifying the 
genotype combination between two SNPs of a specific subject only once rather than φ 
times.  
In GWAS studies, response variables are usually phenotypes, and this approach 
enables the analysis of multiple phenotypes without significantly increasing the 
computational cost of the analysis compared to running just a single phenotype. Most 
common diseases have multiple subtypes; this is a key feature that will enable testing 
for epistatic effects associated with specific subtypes of diseases.  
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1.2.4 Evaluation of significance through replication 
In this thesis dissertation we explore existing methodologies of testing for replication 
between independent genetic studies in order to identify statistically significant results 
[27,29]. However, we also propose some post-processing steps for replicated results 
that enable both the visualization of the distribution of each effect among the genotype 
combinations of the two SNPs as well as studying the correlation of the effects 
between the two studies.  
When comparing p-values between two studies only the total association level of the 
test in each study is compared. The distribution of each effect among each of the 
genotype combinations of the two SNPs is not considered. If a replicated result is 
indeed a true positive, then it’s expected that the signals for each effect will be 
similarly distributed between the two datasets. Failure to do so may be due to many 
factors and can’t be used as a test for non-replication success. In the case of a high 
correlation of the distribution of effects (both main and interaction) to the genotype 
combinations of the two SNPs the confidence in the validity of the results will be 
significantly increased [3,5,27,29].  
If an independent replication study is not available then the same approach of drilling 
down into results in order to visualize the direction and level of the signal of each 
effect on each of the genotype combinations is still helpful. Even though it will not 
help in increasing the confidence in the result, it will help identify the possible 
haplotypes that are more frequent in each phenotype class enabling researchers to 
generate new hypotheses that they may be able to test with follow up experiments.  
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1.2.5 Hybrid cluster cloud high performance computing (HCC-
HPC) framework 
The computing resources available for this work were composed of two different HPC 
systems. They each had distinct characteristics that disabled them from being used 
alone for this analysis [30]. A distributed analytical approach is proposed that enables 
the use of both HPC resources in parallel enabling improvements in efficiency of the 
proposed framework. The proposed approach is compared to using either HPC 
architecture alone, or both. This proposed distributed analytical approach is however 
not applicable to other problems since it’s problem specific to the subject of complete 
two SNP interaction testing, thus it’s labelled as a minor contribution to distinguish it 
from the other presented contributions.  
The proposed computing framework is labelled as a hybrid cluster – cloud high 
performance computing framework (HCC-HPC). This is composed of an algorithm 
that is designed to work for two SNP interactions testing in such a way as to utilize 
both a cloud and a cluster grid to avoid the bottlenecks associated in each. This is 
achieved by breaking up the data into work nodes with each work node going through 
a serial pipeline from the analysts’ personal computer to each of the two HPC systems 
and performing the computationally intensive part of the analysis on the 
computational cloud, leaving the parts that require both computational power and 
inter-process communication to the cluster. The performance of this Hybrid HPC is 
discussed in comparison to performing the analyses on either HPC alone or both.  
 
Publications that were derived as part of this work are listed in Appendix A . 
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1.3 Structure of this dissertation   
This dissertation is split into 7 chapters. In chapter 2 background knowledge will be 
presented to introduce the reader to key relevant concepts of this thesis. Chapter 3 
presents a detailed literature review that was performed in the fields relating to the 
innovations introduced in this dissertation. The proposed framework is presented in 
detail in chapter 4. All results related to the actual analyses of the datasets as well as 
results related to the performance of the system are presented in chapter 5. A 
discussion of the results and the implications of this work are presented in chapter 6. 
Future work is presented on chapter 7. 
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Chapter 2  Background Knowledge 
The goal of this chapter is to introduce some background information as to enable a 
clear understanding of the following chapters and a common terminology related to 
GWAS analyses. The first part of this chapter begins with some basic concepts in 
Molecular Biology, with a focus of explaining SNPs, the markers that the genetic data 
used in this dissertation is consisted of, and Linkage Disequilibrium, an effect that is 
of key importance in all analytical genetic approaches. It concludes with an 
introduction to Complex diseases and genetic and environmental factors that are both 
useful to define in order to understand the motivation for this work. The second part of 
this chapter focuses on statistical genetics, defining a key terminology and providing 
an explanation of key effects and analytical approaches relevant to this work.   
2.1 Molecular biology and medical genetics 
Molecular biology is the branch of biology which primarily deals with functions, 
characteristics and structures of three major macro-molecules DNA, RNA and 
proteins. In this section some basic biological mechanisms from molecular biology are 
presented to enable better understanding of the work in this dissertation. The general 
problem the proposed methodology tries to address falls within the field of human 
genetics. In human genetics the study is focused on inheritance in humans. Study of 
human genetics can answer questions about human nature, understand diseases and 
help in the development of effective disease treatments. However, to date these 
promises have not been met, and part of the problem as described in chapter one is the 
lack of a comprehensive framework to test for gene-gene interactions associated with 
complex diseases.   
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Figure 1 From DNA to proteins, the biological mechanism 
Lister Hill National Center for Biomedical Communications, US National Library of Medicine, 
National Institutes of Health, Department of Health & Human Services, Genetics Home 
Reference. Your Guides To Understanding Genetic Conditions. United States: U.S. National 
Library of Medicine, 2011. 
28 
 
2.1.1 Macromolecules DNA, mRNA and proteins  
Deoxyribonucleic acid otherwise known as DNA is the building block of life. It 
contains the information the cell requires to synthesize proteins and to replicate itself. 
The central dogma of life; the coded genetic information hard-wired into DNA is 
transcribed (transcription is the process of creating a complementary mRNA molecule 
from a DNA segment) into mRNA molecules; each mRNA molecule contains the 
information for the synthesis of a particular protein. As Figure 1 demonstrated mRNA 
molecules can travel outside of the nucleus and into the cytoplasm, here they can be 
translated into proteins.  
2.1.2 SNPs  
A single-nucleotide polymorphism (SNP, pronounced snip) is a DNA sequence 
variation occurring when a single nucleotide in the genome differs between members 
of a biological species or paired chromosomes in an individual [31].  
All individuals have two strands, one inherited by each parent. Figure 2 depicts two 
strands. If we consider these to be from a single individual, then he has a heterozygote 
genotype for the SNP highlighted. Subjects who have the same allele on both strands 
are called homozygote. In the case shown in Figure 2 the two alleles of the SNP are C 
and T.  
Although there are several types of polymorphisms that can occur on a disease 
causing gene, the majority of them can potentially be represented by one type of 
mutation, single nucleotide polymorphisms (SNPs). Therefore SNPs serve as 
biological markers for pinpointing a disease on the human genome map. This does not 
mean that the SNPs cause the disease even though some times that is the case. Simply 
put, due to the way that DNA is inherited, SNPs neighbouring a mutation (potentially 
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disease causing) of any type have a higher probability to be inherited together than 
normal distribution and linkage equilibrium would dictate. The reason for this effect is 
linkage disequilibrium, discussed in at length in a following section. Therefore the 
SNPs with a high probability of being inherited together with a disease causing 
polymorphism will carry that same association with the disease even though they are 
not the causative factor [31,32,11]. 
___________________________________________________________________________ 
 
___________________________________________________________________________ 
 
Figure 2 A SNP on DNA strands 
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2.1.3 Genes 
Genes are stretches of DNA that code for a type of protein or an RNA chain that has a 
function in the living organism [31]. Genes determine hereditary traits, such as the 
hair and eye colour or disease predisposition by providing instructions for how every 
activity in every cell of our body should be carried out [31,33]. Due to the multiplicity 
of polymorphism combinations inherited by each organism different forms of the 
same gene exist in subgroups of individuals. These forms are called alleles. When a 
gene is in the process of being transcribed into a functional protein the number of 
copies of mRNA sequences for that gene can be counted through “gene expression” 
experiments [34].  
To better understand the functionality of genes, here’s a classic example. A gene may 
enable a liver cell to remove excess cholesterol from our bloodstream. It does this by 
instructing the cell to make a particular protein. It is this protein that then carries out 
the actual work. In the case of excess blood cholesterol, it is the receptor proteins on 
the outside of a liver cell that bind to and remove cholesterol from the blood. The 
cholesterol molecules can then be transported into the cell, where they are further 
processed by other proteins [35]. 
Many diseases are caused by polymorphisms or changes in the DNA sequence of a 
gene. When the information coded for by a gene changes, the resulting protein may 
not function properly or may not even be produced at all. In either case, the cells 
containing that genetic change may no longer perform as expected. For example, we 
now know that mutations in genes code for the cholesterol receptor protein associated 
with a disease called familial hypercholesterolemia. The cells of an individual with 
this disease end up having reduced receptor function and cannot remove a sufficient 
amount of low density lipoprotein (LDL), or bad cholesterol, from their bloodstream. 
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A person may then develop dangerously high levels of cholesterol, putting them at 
increased risk for both heart attack and stroke [35]. 
2.1.4 Linkage disequilibrium 
Linkage disequilibrium is the non-random association of alleles at two or more loci, 
not necessarily on the same chromosome [8,31]. In other words, linkage 
disequilibrium is the occurrence of some combinations of alleles or genetic markers in 
a population more often or less often than would be expected from a random 
formation of haplotypes from alleles based on their frequencies. The amount of 
linkage disequilibrium is the difference between observed and expected (assuming 
random distributions) allelic frequencies [7,36]. 
Linkage disequilibrium can be visualized in a map that presents the LD between two 
SNPs by using an LD metric. LD metrics are tests of associations between two 
markers such as SNPs typically applied to a single group of subjects that is 
representative of the general population. HAPLOVIEW is the traditional software for 
performing and visualizing LD analyses [7,37]. A sample of HAPLOVIEW’s output 
is presented in Figure 3. 
The horizontal line at the top of the map represents a DNA strand. The vertical lines 
on it represent genotyped SNP locations. Below that all genotypes SNPs are put in 
series with a line connecting them to their position on the DNA strand. The LD map 
generates an equilateral triangle so that two of the vertices of the triangle are placed 
on the SNP location on the map and the third vertice is represented by a small 
rhombus. The colour of the rhombus represents the level of LD between the two 
SNPs. In this example, three categories are plotted, High LD, No LD, and Low LD as 
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red, blue and green respectively. All SNP pairs in this small region are calculated for 
LD.  
Visualization of LD or any other genetic variation on genetic maps generated from 
published studies is possible through the HapMap project [36] that provides the 
functionality and tools to query any region of the human genome. 
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Figure 3 Linkage disequilibrium map example 
Generated from HAPLOVIEW software on a sample dataset[37].  
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2.1.5 Complex versus Mendelian diseases  
Mendelian diseases are diseases where one gene is responsible for one disease. These 
diseases are often rare (such as MCKD1 and MCKD2 researched by the Cyprus 
Institute of Neurology and Genetics) [38]. Linkage analyses were most often used, 
rather than association studies, to discover these Mendelian disease causing genes.  
Complex diseases, otherwise known as multigenic diseases, are caused by more than 
one gene or SNP. Environmental or other factors may also play a role. Thus the 
problem of identifying causative factors in these diseases is far more complex since a 
combination of SNPs will predispose a person in a certain degree to a disease. 
Furthermore, it is believed that for some of the most common complex diseases 
(diabetes, Alzheimer, etc) genetic variations in many or all chromosomes are the 
causes [3,26,29].  
In whole genome analyses, SNPs from the entire genome are involved. This type of 
research requires the analyses of up to hundreds of thousands or even millions of 
SNPs that may be associated to the disease by themselves, or through interaction with 
other genetic loci or environmental factors [3]. The increased number of SNPs needed 
for this type of research and the reduced number of patients’ data that is usually 
available for analysis, due to the high cost of genotyping (determining the genotype of 
SNPs on their DNA), is what makes GWAS studies challenging to conduct. 
Nevertheless, multiple studies have being conducted in many complex diseases. 
2.1.6 Genetic and environmental factors 
For the most part, complex diseases are caused by a combination of genetic, 
environmental, and lifestyle factors, most of which have not yet been identified 
[15,34,39,40]. The vast majority of diseases fall into this category, including several 
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congenital defects and a number of adult-onset diseases. Some examples include 
alzheimer's disease, scleroderma, asthma, parkinson's disease, multiple sclerosis, 
osteoporosis, connective tissue diseases, kidney diseases, autoimmune diseases, and 
many more [41]. 
Scientists now know that complex diseases do not obey the standard Mendelian 
patterns of inheritance. Although we inherit genes associated with these diseases, 
genetic factors represent only part of the risk associated with complex disease 
phenotypes. A genetic predisposition means that an individual has a genetic 
susceptibility to developing a certain disease, but this does not mean that a person 
with a genetic tendency is destined to develop the disease. The actual development of 
the disease phenotype depends in a large part on a person's environment and lifestyle. 
While we cannot change our genes, we can alter our lifestyle and environment to 
prevent or delay the onset of such a disorder. Indeed, the interplay between genetic 
and environmental factors in complex disease continues to challenge the research 
community [39]. 
2.2 Statistical genetics 
2.2.1 Response - explanatory variables terminology in genetics 
The terms “dependent variable” and “independent variable” are used in similar but 
subtly different ways as part of the standard terminology in statistics. They are used to 
distinguish between two types of quantities being considered, separating them into 
those available at the start of a process and those being created by it, where the latter 
(dependent variables) are dependent on the former (independent variables). 
However, in real life applications of statistical approaches in data mining, or statistical 
genetics, independent variables are rarely statistically independent, therefore the terms 
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response variable and explanatory variable are preferable instead of dependent and 
independent variable [42,43]. For the purposes of this dissertation the response 
variable (independent variable) will be composed of phenotypes, while the 
explanatory variables will be composed of SNPs. The terms response and explanatory 
variables will be used, but in the context of this dissertation they should be 
respectively equivalent in terms of statistics to dependent and independent 
respectively.  
2.2.2 Regression analysis 
In statistics, regression analysis includes any techniques for modelling and analyzing 
several variables, when the focus is on the relationship between a response variable 
and one or more explanatory variables. Regression analysis defines how the typical 
value of the response variable changes when any one of the explanatory variables is 
varied, while the other explanatory variables are held fixed [14]. Most commonly, 
regression analysis estimates the conditional expectation of the response variable 
given the explanatory variables — that is, the average value of the dependent variable 
when the independent variables are held fixed. Less commonly, the focus is on a 
quintile, or other location parameter of the conditional distribution of the response 
variable given the explanatory variables. In all cases, the estimation target is a 
function of the explanatory variables called the regression function. In regression 
analysis, it is also of interest to characterize the variation of the response variable 
around the regression function, which can be described by a probability distribution 
[44]. 
In genetic studies, regression analysis can be applied to test for association or 
interaction (dependent on the model used) between multiple loci (explanatory 
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variables) and a phenotype (response variable) such as disease status (case-control). 
For categorical phenotypes logistic regression is typically applied to test for 
interaction between loci, while for continuous phenotypes linear regression can be 
used [45].  
2.2.3 Testing the null hypothesis 
Interpretation of statistical information can often involve the development of a null 
hypothesis (H0) in that the assumption is that whatever is proposed as a cause has no 
effect on the variable being measured [45]. Hypothesis testing works by collecting 
data and measuring how probable the data are, assuming the null hypothesis is true. If 
the data are very improbable, usually defined a-priory as observed less than 5% or 1% 
of the time, then the experimenter concludes that the null hypothesis is false. If the 
data do not contradict the null hypothesis, then no conclusion is made. In this case, the 
null hypothesis could be true or false; the data give insufficient evidence to make any 
conclusion [14,46]. 
Traditionally, research conducted in the biological fields relies on testing the null 
hypothesis as a way to provide a comparable and repeatable measure of an effect. The 
traditional interpretation of testing the null hypothesis is p-values. P-values represent 
the probability of obtaining a test statistic at least as extreme as the one that was 
actually observed, assuming that the null hypothesis is true. A key feature of p-values 
is that the probability provides a combination of both the size of the effect (for 
example, confidence in data mining or odds ratio in statistics) and the size of the 
supporting evidence for it (the number of samples in a dataset, such as the support 
measure from data mining). 
  
38 
 
2.2.4 Statistical significance and multiple testing problem 
The statistical significance of a result is the probability that the observed effect in a 
study occurred by pure chance, and that in the population from which the sample was 
drawn, no such relationship exist [47,48]. The higher the  probability of error that is 
involved in accepting an observed result as a representative of the population, the less 
confidence there is that the observed relation between variables in the sample is a 
reliable indicator of the relation between the respective variables in the population 
[14,42,46]. Specifically, a p-value of 0.05 (i.e.,1/20) indicates that there is a 5% 
probability that the relation between the variables found in our sample is a false 
positive. In other words, assuming that in the population there was no relation 
between those variables whatsoever, and we were repeating experiments, it’s expected 
that approximately in every 20 replications of the experiment there would be one in 
which the relation between the variables in question would be equal or stronger than 
the 0.05 cut-off [6].  
It follows that the more analyses you perform on a data set, the more results will meet 
by chance the conventional significance level. For example, if you perform 40 
independent tests, then you should expect to find by chance that about two (i.e., one in 
every 20) tests are significant at the p-value < 0.05 level, even if the values of the 
variables were totally random and those variables do not correlate in the population. 
Some statistical methods that involve many comparisons and, thus, a good chance for 
such errors include some “correction” or adjustment for the total number of 
comparisons. However, many statistical methods (especially simple exploratory data 
analyses) do not offer any straightforward remedies to this problem. Therefore, it is up 
to the researcher to carefully evaluate the reliability of unexpected findings. In this 
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dissertation this will be referred to as the multiple testing problem, a common 
terminology used [22,23,24].  
If there are very few observations (in the case of GWAS very few subjects), then there 
are also respectively few possible combinations of the values of the variables and, 
thus, the probability of obtaining by chance a combination of those values indicative 
of a strong relation is relatively high. This is the same problem as having to deal with 
low support but high confidence in data mining.  
Consider this example from research on statistical reasoning [49]. There are two 
hospitals: in the first one, 120 babies are born every day; in the other, only 12. On 
average, the ratio of baby boys to baby girls born every day in each hospital is 50/50. 
However, one day, in one of those hospitals, twice as many baby girls were born as 
baby boys. In which hospital was it more likely to happen? The answer is obvious for 
a statistician, but as research [49] shows, not so obvious for a lay person: it is much 
more likely to happen in the small hospital. The reason for this is that the probability 
of a random deviation of a particular size (from the population mean), decreases with 
the increase in the sample size. 
If a relationship between variables in question is small, then there is no way to identify 
such a relation in a study unless the research sample is correspondingly large. Even if 
our sample is in fact “perfectly representative”, the effect will not be statistically 
significant if the sample is small. Analogously, if an association in question is very 
large, then it can be found to be highly significant even in a study based on a very 
small sample. 
In the case of genetic analyses on high dimensional GWAS, the number of predictor 
variables is very high (on the dataset used to evaluate the performance of this system 
550,000). However, the number of samples (in this case subjects) is comparably small 
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(roughly 2000). This is due, in one hand the difficulty of finding criteria matching 
cases of a disease under study and second on the large cost of associated with finding, 
evaluating, collecting data and consent forms from large sample populations. To make 
matters even worse, it is commonly believed that the current classification of most 
diseases is likely to have multiple different genetic factors contributing to them. In 
terms of the biological mechanisms involved there may be completely different 
genetic mechanisms involved that exhibit the same phenotypes and were thus 
classified together as a single disease. This reduces further the statistical power of 
detecting such effects in GWAS but it also provides a good argument for the analyses 
of disease subtypes [50]. 
2.2.5 Main effect 
In the design of experiments and analysis of variance, a main effect is the effect of an 
independent variable on a dependent variable averaging across the levels of any other 
independent variables [51]. The term is frequently used in the context of factorial 
designs and regression models to distinguish main effects from interaction effects. 
2.2.6 Epistasis  
In genetics, epistasis is the phenomenon where the effects of one gene are modified by 
one or several other genes, which are sometimes called modifier genes. The gene 
whose phenotype is expressed is called epistatic, while the phenotype altered or 
suppressed is called hypostatic. Epistasis can be contrasted with dominance, which is 
an interaction between alleles at the same gene locus.  
In general, the fitness increment of any one allele depends in a complicated way on 
many other alleles; but, because of the way that the science of population genetics was 
developed, evolutionary scientists tend to think of epistasis as the exception to the rule 
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[3]. In the first models of natural selection devised in the early 20th century, each gene 
was considered to make its own characteristic contribution to fitness, against an 
average background of other genes [1].  
Epistasis and genetic interaction refer to different aspects of the same phenomenon. 
The term epistasis is widely used in population genetics and refers especially to the 
statistical properties of the phenomenon, and does not necessarily imply biochemical 
interaction between gene products. However, in general, epistasis is used to denote the 
departure from “independence” of the effects of different genetic loci. Confusion often 
arises due to the varied interpretation of “independence” between different branches 
of biology. For further discussion of the definitions of epistasis, and the history of 
these definitions, see [3]. For the purposes of this dissertation the term epistasis is 
used to refer to the statistical properties of the phenomenon.  
The presence of epistasis can have important implications for the interpretation of 
statistical models. If two variables of interest interact, the relationship between each of 
the interacting variables and a third “dependent variable” depends on the value of the 
other interacting variable. In practice, this makes it more difficult to predict the 
consequences of changing the value of a variable, particularly if the variables it 
interacts with are hard to measure or difficult to control [5]. 
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Chapter 3  Literature Review 
A detailed review of the areas of research associated with the original contributions of 
this work is presented in this chapter. Existing proposed solutions to these problems 
are identified and described. Performance parameters are identified for every problem 
to enable a structure comparison methodology for the different approaches to 
addressing each problem. The first look is at different ways of encoding GWAS data. 
Then a look at the measures used to quantify epistatic effects. Ways of computing 
contingency tables are looked at followed with literature on significance testing 
through replication. Finally, attempts to address the problem of providing a 2 SNP 
interaction testing  methodology are listed, split into two categories, those that focus 
on utilizing an HPC so that a near exhaustive search can be performed and those that 
rely on data mining techniques to identify significant effects while only spanning a 
small subset of the search space.  
3.1 Data encoding 
When the work for this framework started, the only widely available non proprietary 
format for storing GWAS data was the QTDT MERLIN format [12]. While however 
the work for research and development was taking place another format was 
developed by a different group referred to as PLINK binary format, after the software 
that it was introduced in [13]. Key limitations of the encoding in the PLINK binary 
format were discovered. Therefore through the work proposed in this dissertation an 
alternative format was developed and published. In this section the commonly used 
format introduced in the software MERLIN [12] and the newer binary encoding 
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introduced in PLINK [13] are discussed and in the following chapters a newer 
encoding that was proposed as part of this dissertation is introduced. 
3.1.1 The MERLIN format 
The file format described in MERLIN [12] is the one traditionally used for this type of 
data. It is split into three files: pedigree, map and data files. Pedigree files contain 
phenotypes for discrete and quantitative traits and marker genotypes for a specific 
number of subjects. They are usually white-space delimited files. The first (usually 6) 
columns contain information about the subject (Family ID, Individual ID, Paternal ID, 
Maternal ID, Sex, Phenotype). The combination of the information of each subject 
must be unique. The next columns contain bi-allelic markers; typically SNPs. Marker 
genotypes are encoded as two consecutive integers, one for each allele, or using the 
letters “A”, “C”, “T” and “G”. To denote missing alleles a sentinel value is used, 
typically “0”. An example of a sample ped file is provided in Table 1. It’s worth 
noting that the Merlin format is designed to support pedigree or lineage studies, were 
the subjects included in them are related. All studies relevant to this dissertation are 
case-control though and are designed to exclude related individuals, so each subject is 
from a single family family.  
Map files contain information for each single nucleotide polymorphism. They are used 
to analyze genetic markers into the equivalent pedigree file. Each line per marker 
usually contains 3, 4 or 5 columns (chromosome, SNP identifier, morgans or 
centimorgans and base-pair position). Each column is separated by white space.  
Dat files describe the pedigree file. They include one row per data item in the pedigree 
file, indicating the data type providing a one-word label for each item. 
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Table 1 A sample Merlin format pedigree file 
Family Person Father Mother Gender Disease SNP1 SNP2 ... SNPn 
1 1 0 0 m 1 AT GA ... CG 
2 2 0 0 m 1 00 GA ... CC 
3 3 0 0 f 1 AA AA ... CG 
4 4 0 0 m 1 TT 00 ... GG 
5 5 0 0 f 2 AT GA ... 00 
6 6 0 0 f 2 AA GA ... CC 
 
*0 is used to encode missing data.  
* Disease is given as 1 for controls, 2 for cases 
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3.1.2 PLINK’s Method for binary ped files 
PLINK is an open source program offering a comprehensive range of basic large-scale 
whole genome association analysis methodologies. It has been widely adopted since 
high dimensionality GWAS have become available as it enables researchers to 
efficiently analyze these large datasets in a computationally efficient manner.   
In PLINK there is an encoding format for transforming QTDT MERLIN data into 
binary formatted files. The approaches used in PLINK uses 2 bits for encoding bi-
allelic markers with 4 possible states. PLINK uses the encoding for each genotype 
given in [13]. 
Testing on PLINK binary format showed that the exported binary file was 15 times 
smaller than the original file. The drawback however is that encoding of the 
heterozygote allele is the same regardless of what strand it’s actually derived from. 
Therefore any analyses that rely on the sequence of the alleles on the strand will be 
missing this information.  
One analysis technique that needs the lost information is imputation.  Imputation 
analysis is the practice of “filling in” missing data with plausible values. It is a method 
for uncovering the genetic basis of human disease and it is used for inferring 
genotypes at observed or unobserved SNPs that can detect causal variants that have 
not been directly genotyped [9]. It is in essence an in-silico approach to discover the 
probability of the existence of a specific genotype for loci that haven’t been directly 
genotyped but are known to be in LD with genotyped markers. 
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Table 2 PLINK binary format data encoding [13,52] 
Allele On Strand + Allele On Strand - Marker Encoding 
A A 00 
A 
a 
a 
A 01 
A a 11 
Missing Data  Missing Data 10 
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3.2 Measures of epistasis 
The gold standard for a statistic that measures the epistatic effect is regression 
analysis. Since in this dissertation the focus is on categorical response variables, the 
gold standard used will be logistic regression. There are two different measures that 
researchers are most interested in. These are testing for interaction between two 
factors, and test for association allowing for interactions [3,8,26,32]. In this research 
work, the proposed test for interaction is referred to as the epistasis test, while the 
omnibus test falls in the category of tests for association allowing for interaction. The 
difference is that epistasis only measures the interaction between the two SNPs, while 
the omnibus effect represents the combined effect of the main effects of the SNPs and 
the epistatic effect itself. Logistic regression can be used to derive both a test of 
interaction as well as a test allowing for interaction, thus it traditionally forms the 
standard by which to benchmark any new proposed methodologies [32]. 
 However, logistic regression is computationally demanding. In order to develop any 
methodology that attempts to perform testing at the whole genome scan level even on 
a relatively small subset of SNPs faster measures are needed [32,53]. Thus some 
alternatives to logistic regression have been introduced. All of the proposed 
methodologies are compared to logistic regression. Similarly in this dissertation the 
proposed methodology will be compared with logistic regression as well. 
Table 3 gives an overview of each of the proposed methods in the literature for 
performing a two SNP interaction test,. The table indicates for each test the following: 
 Epistasis test: Does the method provide a statistic measure of the interaction 
between the two SNPs (epistatic effect). 
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 Allowing for epistasis test: Does the method provide a statistic measure of 
association between two SNPs allowing for the epistasis test, that is a test of 
the two main effects and the interaction between them combined as in the 
omnibus test proposed in this dissertation. 
 Response variable: List of all possible types of response variables the method 
can analyze. Some methods such as regression can analyze more than one type 
of response variable (i.e. logistic regression tests for categorical response 
variables and linear regression for continuous response variables). 
 Adjustment of covariates: Occasionally, a known bias may exist in a dataset, 
or it may be thought to exist. Adjusting by covariates removes this bias from 
the test performed.  
 Marker type: In genetics there are two possible ways to consider SNP data. 
The first is the allelic approach, where each allele is scored independently, and 
the second is the genotypic approach where each genotype, that is the alleles 
on both strands for a specific SNP is considered.  
 Tested on real data: Has the measure being tested on real data in a peer 
reviewed publication providing evidence to its performance.  
 Replicated Result: Has an analysis applying the specific measure produced 
replicated statistically significant results in independent datasets.  
 Bias: Are there any known biases in the proposed measure that may affect it’s 
accuracy.  
 Results interpretation: How are the results interpreted. The preferred 
interpretation is as the probability of getting the same result as a false positive 
(p-value). 
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 Computational requirements: The computational requirements of each method 
are ranked as high, medium or low based on published reviews of the methods.  
 References: A list of references related to each method, either publications 
introducing or reviewing the methods. 
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Table 3 Comparison of existing measures of epistasis using statistical or data mining approaches 
 
*MAF= minor allele frequency 
*LD= Linkage Disequilibrium 
 
Measures 
Epistasis 
test 
Allow 
for 
epistasis 
tests 
Response 
variable 
Adjustment 
by 
covariates 
Marker 
type 
Tested 
on real 
data 
Replicated 
results 
Bias 
Result 
interpretation 
Scalability References 
Regression 
analyses 
Yes Yes 
Categorical, 
linear 
Yes 
Genotypic 
Allelic 
Yes Yes 
*LD, in some 
cases 
p-values Low [13,54,55] 
Odds ratio 
Multiplicativ
e Interaction 
Yes No Binary No Allelic Yes No 
*LD, *MAF, 
size of dataset, 
Heterozygote 
effects 
Approximated 
p-values 
High [3,32,56] 
Case only 
analysis (χ2 
Yes No Categorical No Genotypic Yes No 
Non linkage 
equilibrium 
p-values, High [13,32] 
Recursive 
Partitioning 
No Yes Categorical No 
Genotypic 
Allelic 
Yes No 
*LD, main 
effects 
None, requires 
follow-up 
analyses 
Medium, 
parameter 
dependant 
[32,57,58] 
Multi-
dimensionali
ty reduction 
(MDR) 
No Yes Categorical Yes 
Genotypic 
Allelic 
Yes No 
*LD, main 
effects 
None, requires 
follow-up 
analyses 
Low [59,60] 
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3.2.1 Logistic regression  
The standard widely accepted measure of the effect of one or more terms in a 
regression model is provided by comparing the deviances obtained from fitting the 
model with and without the term(s) in question [55]. By using regression analysis, an 
allelic or genotypic test can be performed. Linear regression analyses can be used to 
perform interaction testing with continuous response variables rather than categorical. 
Implementations of epistasis test using logistic and linear regression models are 
available in the genetic analysis software PLINK [13] and are widely used [3,8,16,32]. 
This PhD dissertation is focused on categorical response variables and genotypic 
testing, therefore in order to provide a fair comparison between the proposed method 
and logistic regression the corresponding model of logistic regression for genotypic 
analysis of interaction is defined in the methods chapter, and implemented in R a 
statistical package [61].  
3.2.2 Odds ratio multiplicative interaction measure 
As a faster alternative to logistic regression, another measure of interaction for 
epistasis testing sometimes used is an odds ratio multiplicative interaction measure 
[13]. A recent publication [40] also proposed a new methodology for interaction 
testing that draws similarities to this measure. In that work, both a genetic and an 
allelic model of interaction testing based on odds ratio multiplicative interaction 
measure were presented and compared to a proposed pseudo-haplotype based measure 
[40]. They tested their hypothesis by analyzing GWAS in two independent datasets; 
however, they were not able to perform all possible two SNP interactions as in the 
proposed methodology in this dissertation. They cited the extreme computational 
complexity of the problem as the reason for that, although they do indicate it as their 
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future work goal to perform a complete test. They used a heuristic to limit the number 
of SNPs to those that were on genes reported to be involved in a total of 501 
assembled pathways generated by a simple computational approach to reduce the 
number of interactions to test, as well as to increase the likelihood that any results 
found would be in genes involved in pathways of interest. Although they report 
discovering replicated results, these are only evident after they completely analyzed 
both datasets and compared the top results of both analyses. Since this involves the 
creation of two large lists of top results and the testing for overlap between them, it’s 
not clear if the number they get as overlapping deviates significantly from what you 
would expect from a random association or not. An examination of the reported 
replicated interactions for evidence from the literature for their association to the 
disease is attempted in order to improve the confidence in the findings, however, since 
they limited the SNPs they tested by selecting pathways known to be associated with 
the diseases, it’s expected that any false positive results would also be associated with 
the disease. The conclusion reported in this paper is that further research needs to be 
conducted, so that complete two SNP interaction testing is possible in a GWAS.  
3.2.3 Case only analysis with chi-square 
Another proposed way of performing epistasis testing is through a simple association 
test between two markers performed in just the cases, under the assumption of linkage 
equilibrium [32,53]. In theoretical terms, this analysis carries more statistical power, 
but it’s this assumption of linkage equilibriums that doesn’t hold in real data that 
provides that additional statistical power [32]. This approach can easily be extended to 
perform either genotypic analyses or allelic. In genotypic analyses a contingency table 
with size 3*3 will be created with the first SNP having its three genotypes on each of 
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the three columns, while the second SNP’s genotypes will be represented in the rows. 
An allelic test follows a similar approach with a 2 by 2 contingency tables where the 
two alleles of each SNP are represented similarly in the corresponding rows and 
columns. A chi-square statistic or any other test for association applicable to a 
contingency table can reveal the level of association between the two SNPs.  
This approach assumes non independence between LD, much like all other analyses 
presented on Table 3. 
However, this method is affected to a considerably greater degree by non 
independence between markers. The test itself is a test of dependence, and the 
assumption here is that if there is dependence since there is an assumption of linkage 
equilibrium then that dependence must be caused by an epistatic effect associated with 
the disease the cases are subject to. This is not the case, even if two SNPs are on 
different chromosomes; they may still not be in linkage equilibrium. As an example, 
consider a case where two genetic locations do interact and polymorphisms 
combinations within these locations cause the subject’s probability to reproduce to be 
significantly reduced compared to those with different genotypes at those locations. 
The two regions are not in equilibrium since less of the subjects would be expected 
with those specific rare polymorphisms. Thus in this analytical approach, those two 
polymorphisms will be reported as epistatic effects for the disease the cases were 
taken from, even though they may have nothing to do with the disease, and the 
frequencies of those two polymorphisms even though not in equilibrium would be 
very similar to a matching control population.  
An implementation of this approach is presented in PLINK [13] called, case-only 
analysis. In an attempt to reduce the probability of having markers tested together for 
epistasis that are in LD, only tests on markers over a certain distance on the genome 
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are tested, however reviews of this method using real data revealed that the 
statistically significant results can be driven by non linkage equilibrium rather than 
true epistasis associated with the disease.  
3.3 Computing multidimensional contingency 
tables  
Often, data derived from natural sciences, fields that use a scientific method to study 
nature, come in the form of multidimensional tables of counts, referred to as 
contingency tables [62]. Generating contingency tables is a known P hard Problem 
[17]. The classic  problem that scientists have worked on over the years has been how 
to compute the expected cell counts for the different statistical models used in 
analyzing contingency tables efficiently with an acceptable accuracy. In this work 
however, effort was placed in avoiding any methodology that diluted information 
derived from the already weak in terms of statistical power analysis of two SNP 
interaction testing in GWAS. Therefore, when computing multidimensional 
contingency tables, focus was placed on efficiently computing the tables with no 
statistical power loss. In order to do this we focused on the need to count multiple 
contingency tables for different response variables [1,16,41].  
3.3.1 The classical data driven approach 
  Traditionally, when there is a need to count a multidimensional contingency table, 
the standard approach is to go through the data of each subject, and increment the 
count of the contingency table cell he belonged to. A complete pass through all the 
subjects will generate a contingency table for a response variable. However, as is 
often the case in analyzing data derived from natural science studies, there’s more 
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than one response variable that is of interest. In current analytical frameworks of 
GWAS, hypothesis testing is grouped into response variables. The analysis of all 
hypothesis tests relating to a response variable is performed through a single pass of 
the dataset as presented in the form of pseudo code in Figure 4. However, when more 
than one response variable is involved in the hypothesis to be tested the process needs 
to be repeated, resulting in at least as many passes through the data as there are 
response variables.  
Algorithm: Compute Contingency table  
Input: 
 SNP1 genotypes for all subjects 
 SNP2 genotypes for all subjects 
 Array of response variables for all subjects 
 
Output: 
 3dTable: a four dimensional table with all contingency tables in it scored  
 
Description: This function passes through all the subjects in the dataset once and scores 
based on the 2 inputted SNPs genotypes each of the contingency tables in the 3d matrix.   
 
 
1   FOR  all Subjects 
a. Z=ResponseVeriableCategory(Subject)  
b. X=SNP1genotype(Subject) 
c. Y=SNP2genotype(Subject) 
d. 3dTable(Z,X,Y)++;  
 
Figure 4 Computing contingency tables, the traditional approach 
3.3.2 The random walk approach, monte carlo sampling 
Random walk approaches have been tested for this problem [17,19]. The basic 
concept behind all random walk approaches, is that a subset of the population can be 
counted that is sufficiently large to get an acceptable estimate of the actual count, had 
a complete count of the data taken place. The second type of random walk approaches, 
are not done to increase the computational efficiency, but to increase the statistical 
power. A recent example is the use of monte carlo sampling methods using Markov 
chains as presented in [18]. Neither of these methods however has gained popularity, 
mostly because they only provide a linear improvement in time based at a cost of not 
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testing the entire dataset. Since lack of statistical power is a key problem in this type 
of analysis, counting all subjects in the contingency tables takes priority over any 
method that only provides a linear increase in computational performance. 
3.4 Evaluation of significance through replication 
Replication testing is the cornerstone of evaluation of any finding in genetics 
[11,27,29,32,63]. Many reported strong genetic associations that made sense based on 
the knowledge of the relation of the underlying gene and the disease it was tested for 
were reported from a single study, but later failed to replicate in follow up analyses of 
independent datasets [29,27]. Even though failure to replicate doesn’t necessary mean 
that the result is not a true positive as it could in theory be an effect with higher 
frequency in the population under study and therefore with more power of detection in 
that study. Generally, if a genetic marker is reported to have an association to 
phenotype in a single study if it’s not replicated in an independent dataset it is not 
considered robust. 
Replication testing methods can be split into two parts, the first being the verification 
of the effect size. This is easily performed by repeating the analyses with the same 
parameters in an independent dataset. However, even if there is statistical significance 
in both datasets, this may still be a false positive result if the distribution of the effect 
among the genetic markers categories is not the same between the two datasets. The 
next step is to try to acquire more confidence in the finding by examining if the effect 
is distributed similarly between all genotype combinations in both datasets. There are 
two ways to do this, merging the dataset and repeating the test, or examining the 
distribution of the effect across each of the genotype combinations. 
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3.4.1 Combine GWAS and repeat analyses 
 Traditionally to get a more statistical power in an analysis, the independent datasets 
are combined and the analysis is repeated in the resulting dataset that is larger since 
it’s an overset of the two dataset. The generated statistic will have considerably more 
statistical power since the sample size now is the combined of the two datasets, and if 
the effect carrying genotype combinations are matched in direction the resulting p-
value should be stronger than either of the two independent datasets. If it is not, then 
the replication success itself is not considered proof of validity of the result. Even if 
the p-value of the combined dataset is statistically significant though, this does not 
necessarily mean that all genotype combinations carried the same signal in both 
datasets. It just indicates that the ones that did combined with the increased number of 
subjects and the resulting increase in power, provided stronger evidence for the effect.  
3.4.2 Examine the distribution of effects across the genotype 
combinations  
The second way of examining if the replication across two independent dataset was 
successful is to study the distribution of each effect among each of the genotypes in 
cases and controls in the two datasets. Assuming that the result is a true positive then 
the effect size should be similar in both dataset for all genotype + response variable 
combinations. In Univariate allelic analysis the odds ratios are used to study this for 
the main effect. However, simple odds ratios can’t be used in the case of interaction 
testing since there are four degrees of freedom in Epistatic test, and 8 in the Omnibus 
test, and odds ratio’s can be generated only when there are 2 degrees of freedom.  
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The information generated by examining the distribution of effects to the genotypes, is 
interesting to the interpretation of the results as well, as it will identify the key 
conditions that are associated with differences in disease predisposition. 
 
3.5 Analytical frameworks for gene-gene 
interaction testing using GWAS data 
Any solution to two SNP interaction problems in GWAS would need to address the 
problem of the high demand for computing requirements. Thus different researchers 
have attempted different approaches to this problem. In this section the most notable 
of these approaches will be presented so that they can in later sections be compared to 
and discussed in comparison to the proposed framework. Priority was given in 
approaches that attempted to perform exhaustive search, such as in the proposed 
framework, or near exhaustive search.  
Table 5 provides an overview of the methods. These methods can be split into two 
broad categories, ones that rely on HPC computing resources to perform either 
exhaustive search, or near exhaustive search, and the second category is based on 
machine learning, or data mining techniques, that are attempting to identify effects of 
interest by going through only a small part of the search space. Finally, as part of this 
section, the two traditional techniques for filtering the data are explained, the 
candidate gene approach, and the main effect significance approach.  
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3.5.1 Two SNP interaction testing using HPC  
3.5.1.1 Cluster HPC 
 
In Marchini et al [54] highlighted the importance and feasibility of fitting interaction 
models using GWAS data. In that study a 10 node computing cluster was used to 
perform all pair-wise tests of association allowing for interaction on a simulated 
dataset of 300,000 loci in 1,000 cases and 1,000 controls. He quoted a time of 33 
hours on that specific system. The PLINK web site [13], quotes 24 hours to test all 
pair-wise interactions at 1,000,000 loci with 500 subjects although it doesn’t clarify 
what machine they used to verify this and their results are based on estimations using 
odds ratio interaction analyses that they recommend that they are validated trough 
follow up analyses with logistic regression.  
It needs to be kept in mind when considering these numbers that the typical 
association study performed today can have 500,000 or even 1,000,00 markers using 
today’s genotyping technology. And in the near future even higher dimensionality 
genotyping platforms are expected. In order to provide a level field for comparing the 
proposed methodology to the ones already conducted we estimate the runtime of each 
of the analyses if they had used the same dataset as the primary dataset used in this 
work that is composed of 550,000 SNPs with 1,000 case and 1,000 control subjects. 
The estimation is easy since the number of subjects (s) provides a linear change in 
time, and the number of SNPs (n) increases the number of pair wise combinations to 
test by: 
s
nn


2
)1(
  
Based on this estimation, the Marchini et al approach on the same hardware 10 node 
clusters would take 4.62 days. While the PLINK approach would take 166.28 days. 
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Obviously, it would be best if all approaches could be tested on the same hardware 
using the same dataset with possibility of replication. But as described in 0 the 
proposed framework includes a custom hybrid cluster-cloud high performance 
computing platform.  
3.5.1.2 GBOOST: a GPU-based tool for detecting gene-gene interactions in 
genome-wide case control studies 
 
GBOOST is an implementation of BOOST algorithm on a GPU (graphics processing 
chip) [56,64]. It’s based on the Compute Unified Device Architecture runtime 
application programming interface (CUDA) [65]. GBOOST is reported as having a 40 
fold performance improvement over BOOST’s x86 implementation [64] (Table 4). 
 The statistical measure used as described is a derivative of logistic regression but with 
computational optimizations based on the Kirkwood superposition approximation [66] 
is one that attempts to perform a filtering based on the probability of a SNP pair to be 
significant. However, no definitive evidence is provided as to the efficiency of this 
filtering scheme understandably so since a true complete two SNP interaction would 
need to be performed to provide that information. Furthermore, the Kirkwood 
approximation that this approach is based on does not generally produce a valid 
probability distribution (the normalization condition is violated). Watanabe [67] 
claims that for this reason informational expressions of this type are not meaningful, 
and indeed there has been very little written about the properties of this measure.  
The computational performance of BOOST was compared to PLINK in [64]. Results 
are shown in Table 4. 
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___________________________________________________________________________ 
Table 4 Reported time comparisons between PLINK BOOST and GBOOST 
Number of SNPs 
Number of 
Subjects 
PLINK 
(3GHz CPU) 
BOOST 
(3GHz CPU) 
GBOOST 
NIVIDIA 
GTX285 
1,000 5,000 106s <2s  
5,000 5,000 2,703s 42s 1.04s 
10,000 5,000 10,915s 170s 4.11s 
351,542 5,003  60h 1.34h 
These times were taken from [56].  
PLINK is tested with the fast epistasis option (odds ratio based interaction test, not 
regression). 
 The reported times are based on a 3.0GHz CPU with 4Gbytes memory running Windows XP 
pro for BOOST and PLINK while for the GBOOST test an NIVIDIA GTX285 graphics card was 
used [64]. 
Xiang Wan et al., “BOOST: A Fast Approach to Detecting Gene-Gene Interactions in Genome-
wide Case-Control Studies,” The American Journal of Human Genetics (AJHG), vol. 87, no. 3, 
pp. 325-340, September 2010. 
Ling Sing Yung, Can Yang, Xiang Wan, and Weichuan Yu, “GBOOST: a GPU based tool for 
detecting gene-gene interactions in genome-wide case control studies.,” Bioinformatics, vol. 
27, no. 9, pp. 1309-1310, May 2011. 
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3.5.2 Data mining methods 
Dealing with high dimensional data, and non-linear models using regression-based 
methods is often criticized when the data is expected to contain many interacting 
predictor variables resulting in sparse contingency tables (with many empty cells, or 
with cells with less than 5 counts) [68,69,70].  Data mining and machine learning 
methods have been applied as an alternative. These approaches do not attempt to fit a 
single pre-specified statistical model nor do they attempt an exhaustive search. They 
focus on stepping through the search space of possible models, not necessarily 
limiting to two SNP interactions but rather allowing for multi-way interactions. The 
goal is to identify the model that best fits the data in a computationally efficient 
manner. Based on this, in a review of methods for detecting gene-gene interactions in 
[32] Cordell argues, the distinction that is often made between data-mining and 
regression models is to some extend false. McKinney et al [69] provided a good 
overview of the most prominent machine-learning approaches for detecting gene-gene 
interaction. In the next few sections focus is given on approaches that have been 
applied to real data providing good performance indicators as to the validity of their 
results. 
3.5.2.1 Recursive partitioning  
 
Classification and regression trees are the basis of recursive partitioning approaches 
[58]. Trees are constructed based on rules that determine how well a split at a node (in 
this case representing SNP genotypes, or environmental factors) can differentiate 
observations with respect to the response variable. The traditional splitting rule is to 
use the variable that maximizes the reduction in a quantity known as the Gini impurity 
at each node [58]. Nodes are recursively split until either some preset stopping criteria 
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are met (such as the max number of SNPs involved in a rule) or if no further gain can 
be made (if all terminal nodes contain only cases or only controls). An example of the 
recursive partitioning approach steps is given in Figure 5. 
Recursive Partitioning approaches do not test for interactions; rather they test for 
association allowing for interactions by computing paths through the tree that 
correspond to strong associations to the disease. Since however, recursive partitioning 
approaches at the very first stage, are relying on the main effect of SNPs to pick the 
first node to split, the likelihood of finding pure interactions in the absence of main 
effects can be missed [71].  
In Figure 5, SNP 3 maximizes the reduction in the Gini impurity at the first node and 
is therefore chosen for splitting (according to the genotype at SNP 3) the original data 
set of 1,000 cases and 1,000 controls into two smaller data sets. Once a node is split, 
the same logic is applied to each child node (hence the recursive nature of the 
procedure). The splitting procedure stops when no further gain can be made (for 
example, when all terminal nodes contain only cases or only controls, or when all 
possible SNPs have been included in a branch) or when some preset stopping rules are 
met. At this stage, it is usual to prune the tree back (that is, to remove some of the later 
splits or branches) according to certain rules to avoid over fitting and to produce a 
final more parsimonious model [32]. 
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___________________________________________________________________________ 
 
Figure 5 Recursive partitioning approach example 
Heather J Cordell, “Detecting gene-gene interactions that underlie human diseases,” 
Nature Reviews Genetics, vol. 10, no. 6, pp. 392-404, June 2009. 
___________________________________________________________________________ 
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3.5.2.2 Recursive partitioning with ensemble of trees (forest) 
 
Substantial improvements in classification accuracy have been observed by growing 
an ensemble of trees rather than a single tree. A popular approach is the random forest 
approach which has been used in genetic studies [72,73]. In this type of analyses  
improvements in classification accuracy compared to the recursive partitioning 
approach of a single tree can be achieved by growing an ensemble of trees and letting 
them ‘vote’ for the most popular outcome class.  
The most widely used ensemble tree approach is probably the random forests method 
[32,57]. A random forest is constructed by drawing with replacement several 
bootstrap samples of the same size (for example, the same number of cases and 
controls) from the original sample. An un-pruned classification tree is grown for each 
bootstrap sample, but with the restriction that at each node, rather than considering all 
possible predictor variables, only a random subset of the possible predictor variables 
is considered. This procedure results in a ‘forest’ of trees, each of which will have 
been trained on a particular bootstrap sample of observations. The observations that 
were not used for growing a particular tree can be used as ‘out-of-bag’ instances to 
estimate the prediction error. The out-of-bag observations can also be used to estimate 
variable importance in different ways including through use of a permutation 
procedure [32,69].  
A key aspect of this approach is that there is no clear model identifying predictors 
either as associated or interacting. Therefore a follow up approach is required to 
actually test the important predictors output by the random forest approach. However, 
since the number of predictor variables (SNP) is small any method for testing for 
interaction or allowing for interaction can be applied without limitations in terms of 
computational complexity.  
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3.5.2.3 Multifactor dimensionality reduction 
 
Multifactor dimensionality reduction (MDR) seeks to identify combinations of loci 
that influence a disease outcome in a way that would classify it as a test allowing for 
interaction rather than discovering pure interactions. MDR reduces the number of 
dimensions by converting a high dimensional multi locus model to a one-dimensional 
model, thus avoiding the issues of empty or small count contingency table cells.  
The main problem with MDR, as with other exhaustive search techniques, is that it 
does not scale up to allow analysis of large numbers of SNPs. If an exhaustive search 
for the best n-locus combination (within each of ten cross-validation replicates) is 
performed, anything more than a two-locus screen on more than a few hundred 
variables will be computationally prohibitive [32]. For investigation of higher-order 
interactions, MDR is therefore perhaps best suited for use with small numbers of loci 
(up to a few hundred), which have perhaps been identified through some sort of 
informed filtering step. 
MDR’s output is a classification of genotypic classes as either high risk or low risk 
according to the ratio of cases and controls in each class. This approach is considered 
overly simplistic, and improvements that embed a more traditional regression-based 
approach allowing application of the method to continuous as well as binary traits and 
adjustment for covariates, have been proposed [74]. However these make the 
algorithm even slower increasing the problem of scalability.  
MDR has been used to identify potential interacting loci in several GWAS, including 
breast cancer, type 2 diabetes, rheumatoid arthritis and coronary artery disease, 
although to date it is unclear whether any of these identified interactions have been 
replicated in larger samples [32]. 
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3.5.3 Filtering approaches 
Since in all of the methods mentioned above, computational complexity is a major 
issue, one of the classic ways of enabling testing for two SNP interactions in available 
computational resources was to limit the search space. Filtering of the number of 
SNPs is the most obvious choice, due to the exponential growth of the search space 
based on the number of SNPs. The first and most common perhaps approach to 
filtering the number of SNPs was actually derived from the early approach of 
identifying what SNPs to genotype. Before high dimensional GWAS studies were able 
to genotype hundreds of thousands of SNPs at a time at low cost the typical approach 
to identify key SNPs to genotype was through candidate gene studies [75,76]. The 
methodology of filtering to a small number of SNPs in candidate gene studies relies 
on identifying genes, or regions in the genome that are thought to be associated with a 
disease. These are typically identified through an extensive literature review of the 
functional biological and genetic knowledge of the disease. Then once all regions of 
interest are identified tagging SNPs within them would be computed. Tagging SNPs 
are SNPs that are estimated through their LD in the general population to represent the 
majority of polymorphisms within their LD region. A common framework for 
identifying tagging SNPs in multiple populations and regions was provided through 
HapMap [36]. This approach however, limited the search to regions of known interest; 
as a result, it was impossible to identify effects that involved regions outside the 
candidate gene regions. Also, another negative effect that emerged with these 
candidate gene approaches was that once the analysis was complete, no matter what 
the top result was, it was certain to have some association with the disease, as that was 
the inclusion criteria in the study. Therefore, the opportunity of looking for replicated 
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information discovery from other types of experiments relating top results with the 
disease was lost.  
Another typical methodology for filtering of SNPs is to use the univariate analysis 
results to limit the number of SNPs to include in the analyses. In this approach, the 
main effect of each SNP in the GWAS is calculated, and then only SNPs that pass a 
preset threshold of main effect are included in the interaction tests. However, this 
approach will not test pairs of SNPs where one or both of the SNPs have no or very 
low detectable main effect in that specific study. There’s no reason to believe that 
SNPs with low or main effects won’t be involved in epistatic effects.  
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Table 5 Two SNP interaction testing frameworks 
Multi-locus 
Interaction 
testing 
framework 
Computing 
Platform 
HPC Scalable Measures 
Largest 
number of 
tests recorded 
Deterministic Accessibility 
Tested on 
Real data 
Replicated 
statistical 
significance 
References 
Simple 
exhaustive 
search Marchini 
et al 
10 node cluster Yes 
Simple 
association test 
allowing for 
interaction 
300k SNPs 
2000 subjects 
Yes Low No No [54] 
BOOST 
Single core x86 
cpu 
No 
Odds ratio 
based 
interaction 
measure 
351k SNPs 
5000 subjects 
Yes High Yes No [56] 
GBOOST GPU 
Limited 
Scalability 
Binary odds 
ratio based 
interaction 
measure 
351k k SNPs 
5000 subjects 
Yes High Yes No [64] 
Recursive 
Partitioning 
(Tree)  
Symmetric 
multiprocessing 
under 
development 
No 
Follow up 
analyses 
necessary to 
provide 
interpretable 
measure 
Limited to 
only a few 
dozen SNPs 
Depends on 
parameters. 
High for small 
number of tests 
Yes No [58] 
Random Forest 
Symmetric 
multiprocessing, 
in theory HPC 
compatible with 
many 
architectures 
No 
Follow up 
analyses 
necessary to 
provide 
interpretable 
measure 
Limited to 
only a few 
dozen SNPs 
No 
High for small 
number of tests 
Yes No [57] 
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Chapter 4  Two SNP Interaction Framework  
This section describes the methodology of the proposed framework and its evaluation.  
The first section describes the functional requirements that were defined following the 
initial literature review for this work. The algorithmic approach for each original 
contribution is then presented beginning with data encoding that enables lossless data 
size reduction. Then, the proposed statistical measures for testing and allowing for 
epistasis are presented, followed by an algorithm that improves computational 
efficiency when calculating multidimensional contingency tables in a four-
dimensional scoring matrix. An a-priory definition of the steps to verify the 
replicability of the results is also provided. Next an algorithm is proposed that enables 
the use of two independent HPC resources with different architectures in a way that 
significantly improves computational efficiency compared to using either HPC alone. 
Finally, the complete proposed framework for two SNP interaction testing is outlined 
in its entirety. 
4.1 Functional requirements 
Through the literature review it became evident that the following functional 
requirements are the most essential in any new methodology for multi-locus analyses 
to be widely adopted. Identifying and categorizing them helps in both providing the 
structure when presenting the methodology in this section as well as it helps with the 
evaluation of the proposed methodology in the chapters to follow.  
1. Algorithmic 
1.1. Deterministic methodology: Needs to be a deterministic methodology that 
will always produce the same results in the same dataset. 
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1.2. Dimensionality scalability: It should be capable of running GWAS of at least 
500,000 SNPs utilizing existing computational infrastructure and it should be 
capable of scaling up. 
1.3. Avoidance of locus inclusion criteria bias: Quick heuristics that rely on the 
main effects of loci to determine if they will be included in the multi-locus 
analyses should be avoided as this is contradictory to biological knowledge.  
2. Statistical Genetics 
2.1. Capability to test for the epistatic as well as the omnibus effect. 
2.2. Heterogeneity: Any effect of heterogeneity in the data such as linkage 
disequilibrium should be identified and accompanied with ways of detecting 
heterogeneity biased results.  
2.3. Feature bias: The statistical measures used should not be biased towards any 
features of a locus such as the minor allele frequency.  
3. Replication Testing 
3.1. Availability: Repeating the analyses in a possible future replication database 
should be possible.  
3.2. Exploration: The results produced by the method need to be presented in a 
user-friendly, familiar, and highly scalable environment that enables querying 
and visualization.  
 
4.2 Data encoding 
When designing the encoding of the data, focus was given to providing an encoding 
that doesn’t reduce the amount of information in the data in any way. This would 
enable backing up the data in this encoded format and keeping it in the HCC-HPC 
after the analyses. This would also enable the performance improvement of future 
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analyses of any other type that uses the same encoding since if the analysis is 
performed on the same distributed high performance computing resources the data 
transfer of the data to nodes will be significantly reduced. Performance improvement 
of future analyses is only applicable when the data remains on the nodes and some of 
the same nodes are available for the analyses however.  
Since some analyses such as imputation (a type of statistical analyses aimed at 
substituting missing values with ones estimated in-silico based on LD of the missing 
data with existing ones for every subject) requires knowledge of which strand the 
alleles of heterozygote SNPs exist on, we need to encode each allele on each strand 
separately for all cases. There are a minimum of three states each allele can be in, 
these include the two possible nucleotides (commonly denoted as A and a) as well as 
the possibility of missing data at that location. The smallest number of bits that can 
encode the 3 states of an allele is 2, however with 2 bits we can actually encode a 
fourth state. In many existing studies this may not be used, even though it will have no 
impact on the capacity requirements the databases will have for storage. However, we 
propose that the fourth state is set to denote markers that are in deleted regions. This 
utilizes the extra available coding to identify a deleted allele from a missing allele due 
to quality control concerns, or genotyping error when that information is available. 
This proposed encoding was peer-reviewed and published in [52].  
An analytical technique that enables the detection of these deletions that has started 
being applied is copy number variants (CNV) analyses. It refers to the genetic trait of 
differences in the number of copies of a particular region (for example a gene) present 
in the genome of an individual [10, 11]. To perform CNV analyses most algorithms 
rely on raw data from the genotyping platform. CNV algorithms are able to detect 
73 
 
deletion regions as well as regions that are duplicated that may exist in some 
individual’s strands. 
However it should be clearly noted that CNV incorporates more information than just 
deleted regions. It can also detect regions that exist in more than one copy per strand. 
This information is not reflected in the proposed protocol; therefore methodologies 
that use this information would still rely on an external file for that information. 
In the proposed format the data are structured as a two dimensional vector of alleles. 
The first dimension’s size is equal to the number of strands the subject has. Typically 
in humans all chromosomes have two strands with the exception of X and Y 
chromosomes in males that each have 1 strand. In these cases a second strand can 
exist listing the alleles of the second strand on males as missing [52]. 
Each element in the vector of each strand will encode an allele on a single strand. The 
allele will be 2 bits long enabling encoding of a total of four states per allele missing 
data, nucleotide 1, nucleotide 2 or deleted. Table 6 presents the four different states 
that can be coded per allele. The term “Unknown” is used rather than the more typical 
“missing” to denote alleles that it’s unclear what their genotypes are or if they are 
deleted so as not to confuse it with the deleted state that defines alleles that do not 
exist on that strand. 
The two strands in each Subject’s vector need to be perfectly aligned, that is, the i th 
element of each vector will point to the same marker’s alleles one for each strand. To 
access the i’th marker’s alleles the two bits at position i in each strand will carry a 
total of 4 bits, using the encoding column of Table 3. To access the i’th marker’s 
alleles the two bits at position i in each strand will carry a total of 4 bits, using the 
encoding column of Table 3 as shown in Table 7. 
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Table 6 Proposed allelic Encoding  
Allele Encoding 
Unknown 00 
A 01 
a 10 
Deleted 11 
 
Table 7 Proposed SNP genotype encoding 
Allele 1 Allele 2 Encoding 
Unknown Unknown 0000 
Unknown A 0001 
Unknown a 0010 
Unknown Deleted 0011 
A Unknown 0100 
A A 0101 
A a 0110 
A Deleted 0111 
a Unknown 1000 
a A 1001 
a a 1010 
a Deleted 1011 
Deleted Unknown 1100 
Deleted A 1101 
Deleted a 1110 
Deleted Deleted 1111 
  
75 
 
4.3 Measure of epistasis 
In order to provide a fair comparison between the proposed and traditional approaches 
to interaction testing, all test statistics need to be testing identical hypothesis as the 
proposed measures. Thus the statistical model used in the logistic regression analyses 
needs to be defined to match the test proposed. In PLINK, although a logistic 
regression measure is proposed, it is based on an allelic analyses, however this 
dissertation work has focused on a slightly more complex and perhaps closer to 
biological reality genotypic model, thus it needs to be defined.  
The input to both the proposed and the test statistic are the contingency table for the 
tests. In the case of the main effect, a two dimensional contingency table made up of 
categories of the response variable as rows and the three possible genotypes of the 
SNP tested as columns. In Table 8 the subject type phenotype that defines if a subject 
is a case or a control is used as the response variable. The number of columns will 
always be three in this type of analyses (the number of genotypes of a bi-allelic SNP); 
however the number of rows depends on the number of categories in the response 
variable used. To identify the different counts of the cells the label U is given to 
represent main effect contingency tables.  
Table 8 Contingency table for a single SNP 
 aa aA AA 
Case U00 U01 U02 
Control U10 U11 U12 
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Table 9 is used directly to estimate the omnibus effect by performing a Pearson’s chi 
square statistic analyses. It’s in reality not a two but three dimensional as shown in 
Figure 6, with each SNP taking up its own dimension. When referring to cells on this 
table the letter M will be used. 
 
Table 9 Contingency table for two SNPs (2d representation) and response 
variable disease status 
 aa bb aa Bb aa BB Aa bb Aa bB Aa BB AA bb AA bB AA BB 
Case M000 M001 M002 M010 M011 M012 M020 M021 M022 
Control M100 M101 M102 M110 M111 M112 M120 M121 M122 
 
 
___________________________________________________________________________ 
 
Figure 6 Contingency table for two SNPs (3d representation) and response 
variable disease status 
___________________________________________________________________________ 
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4.3.1 The proposed measure 
The effect of a single marker’s association to a phenotype (main effect) can be 
expressed by the following model [2][47]: 
ii
i
i
p
p
 





1
log  
where 
 pi = observed proportion of subjects having the ith genotype at Locus A that 
display the phenotype 
  = overall log(probability) that a subject displays the phenotype. 
 i = main effect of the ith genotype at locus A. 
 i = residual effect on the term on the left hand side of the equation (the 
response variable). 
Most current research in genetics is concentrated on this type of effect, testing the 
following null hypothesis: 
H0(1): i = 0 for all i. 
For the purpose of this dissertation study, this hypothesis is tested by the Pearson’s 
chi-square test [77] for association between the row and column classifications in the 
contingency tables presented in Table 8 and Table 9. 
There is a contingency table for each SNP that is used to estimate the Pearson’s chi-
square for the main effect (two degrees of freedom) of each SNP and a contingency 
table for each two SNP combination used to estimate the omnibus effect (eight 
degrees of freedom) with the proposed statistical measure as presented on Table 9. 
However, it is possible to extend this model to represent the combined effect of two 
SNPs on the phenotype, interpreted in terms of the main effect of the first SNP, the 
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main effect of the second SNP, and the interaction between the two. The extended 
model proposed in this study can be represented as follows: 
  ijijji
ij
ij
p
p
 
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

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



1
log  
where 
 pij = observed proportion of subjects having the ith genotype at Locus A and 
the jth genotype at Locus B that display the phenotype 
 i = main effect of the jth genotype at Locus B 
 ()ij = effect of interaction between the ith genotype at locus A and the jth 
genotype at locus B 
 ij = residual effect on the response variable.  
and the other terms defined as before. 
The following additional null hypotheses may then be tested: 
H0(2): j = 0 for all j 
H0(3): ()ij = 0 for all combinations of i and j. 
Chi-square statistics and p-values were obtained from the following significance tests: 
i. an omnibus test of the main effects and interaction, i.e. a test of H0(1), 
H0(2) and H0(3) simultaneously, and  
ii. a test of the interaction effect – also known to geneticists as the epistatic 
effect , i.e a test of H0(3) only. 
The omnibus test combines both the additive and interaction effects between two 
SNPs and the phenotype [2]. It was performed using the chi square test for association 
between the row and column classifications in a contingency table of two SNPs such 
as the one in Table 9. Yates’ correction for continuity [78] was used to prevent 
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overestimation of statistical significance when contingency tables have a less than 5 
count.  
Epistasis occurs when one genetic variant modifies the effect of another, i.e. when the 
two SNPs interact. The test of the epistatic effect is performed using the approximate 
additivity of chi-square statistics for orthogonal effects [46], to obtain the test statistic 
2
B effect,main 
2
A effect,main 
2
A.B omnibus,
2
A.B epistasis,    
and its degrees of freedom 
)1(4DF
)1(2)1(2)1(8DF
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B effect,main A effect,main A.B omnibus,A.B epistasis,



x
xxx  
where x is the number of categories of the phenotype [2]. 
The algorithmic steps of calculating the proposed omnibus and epistatic effects are 
focus around the Pearson’s chi-square test. The pseudo code for the implementation of 
the chi-square test is shown in Figure 7 . The first step is to generate the totals of each 
row and column entry and of the entire table. The contingency table with all totals is 
shown in Table 10. The expected contingency table is generated that represents the 
expected contingency table under the null hypothesis. The expected contingency table 
along with all the formulas to generate it is shown in Table 11. The formula for 
estimating the chi-square statistic with Yates correction [78] is: 
∑
(             )
 
    
   
     
where O and E are the observed and expected tables respectively, c and r are the 
columns and rows, and the subtraction by 0.5 is done for the Yates correction.  
The function that estimates the proposed omnibus and epistatic effect statistics is 
shown in Figure 8. This function first performs a direct call to the chi square function 
with the observed table of 2 SNP interaction (Table 9) as input. The result is the 
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proposed omnibus test. The next step is to estimate the main effects of the two SNPs. 
To do this there are two possible approaches. The first is to go through the steps as 
outlined in Figure 8, estimating the contingency table for each SNP by adding cells 
from the two SNPs contingency table and then performing a chi square on each 
resulting one SNP contingency table. The second is to estimate the main effect of each 
SNP at the beginning of the process and then just use those to estimate the proposed 
epistasis measure (Figure 8, Step 4) skipping two steps. Although this may seem like a 
nice optimization, in reality it’s not, as in the first approach the contingency tables 
used to generate each SNP would reflect the missing data of both SNPs, while in the 
second case, missing data in one SNP would not be reflected in the contingency table 
of the second. The actual program developed implements both approaches, but 
preference is given to the first, as it provides more accurate results and a fairer, 
estimation of the runtime required.  
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__________________________________________________________________________________ 
Algorithm:  Chi-square 
Input: 
Contingency table to calculate the Peasrson’s chi-square (table noted as O as in 
observed table) 
Output: 
Chi square statistic 
Description: 
  This function will perform the chi square test on a contingency table of any size. 
 
// First step is to estimate the contingency table totals. 
1   FOR  c=0; c<number of columns; c++ 
For r=0; r< number of rows; r++ 
Σc+=O(r,c) 
Σr+=O(r,c)  
FOR all totals in rows tr 
Σall+=tc                                 // Table 10 shows the totals estimated 
2   // Second step, generated expected table. E shown in Table 11 
FOR  c=0; c<number of columns; c++ 
FOR r=0; r< number of rows; r++ 
E(c,r)=(Σc * Σr) / Σall      
Chi_Square=  [O(r,c)- E(c,r) -0.5 ]
2
/ E(c,r) // the -0.5 is for the Yates correction 
 
*All variables are considered to be initialized to 0.  
 
Figure 7 Pseudo code for Pearson's chi-square test with Yates correction for 
continuity 
__________________________________________________________________________________ 
 
Algorithm:  OmnibusAndEpistasisTest 
Input: 
Contingency table for 2 SNPs and a single response variable. (Labelled M as in Table 9) 
Output: 
Omnibus measure 
Epistasis measure   
Description: 
  This function will perform the chi square test on a contingency table of any size. 
 
1. // First step is to estimate the Omnibus measure. This is a simple call to Chi-square. 
Omnibus=ChiSquare(O) // (Figure 7) 
2. // Estimate main effect observed tables (U) and chi square statistic of main effect for SNP1 
adjusted for missing data of both SNP1 and 2 Main1 
For r=0; r< number of rows; r++ 
Ur0= Or,0,0+ Or,0,1+ Or,0,2 
Ur1= Or,1,0+ Or,1,1+ Or,1,2 
Ur2= Or,2,0+ Or,2,1+ Or,2,2 
Main1= Chi-square(U) //main effect of first SNP 
3. // Estimate main effect observed tables (U) and chi square statistic of main effect for SNP2 
adjusted for missing data of both SNP1 and 2 Main2 
For r=0; r< number of rows; r++ 
Ur0= Or,0,0+ Or,1,0+ Or,2,0 
Ur1= Or,0,1+ Or,1,1+ Or,2,2 
Ur2= Or,0,2+ Or,1,2+ Or,2,2 
Main2= Chi-square(U) //main effect of second SNP 
4. //Estimate Epistasis 
5. Epistasis= Omnibus- Main1- Main2 
 
Figure 8 Pseudo code of omnibus and epistasis test function 
___________________________________________________________________________ 
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Table 10 Contingency table with totals estimated 
 aa bb aa Bb aa BB Aa bb Aa bB Aa BB AA bb AA bB AA BB Total 
Case M000 M001 M002 M010 M011 M012 M020 M021 M022 Σcases 
Control M100 M101 M102 M110 M111 M112 M120 M121 M122 Σcontrols 
Total Σaabb ΣaaBb ΣaaBB ΣAabb ΣAabB ΣAaBB ΣAAbb ΣAAbB ΣAABB Σall 
 
 
Table 11 Table of expected values (E) with formulas for estimating it’s cell values from the observed table (O)(Table 10) 
 aa bb aa Bb aa BB Aa bb Aa bB Aa BB AA bb AA bB AA BB 
Case 
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4.3.2 The logistic regression model used as a test statistic 
On the corresponding null hypothesis the change in deviance has a chi-square 
distribution with DF = number of terms dropped, and can be used as a test statistic. 
Thus H0(1) is tested by the change in deviance between the models: 
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Similarly, the omnibus test of H0(1), H0(2) and H0(3) is given by the change in 
deviance between: 
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H0(3) is tested by the change in deviance between: 
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A known bias of Pearson’s chi-square test is overestimation of the statistical 
significance of cells in the contingency tables with small values. Yates’ correction for 
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continuity [78] is used when calculating the chi-square statistic to prevent this. This is 
a very simple, yet very robust method that only involves a single subtraction and it has 
been widely accepted as a valid correction.  
The proposed methodology that relies on the additive property of Pearson’s chi-square 
will be compared to this method referred to in this paper from now on as the logistic 
regression method.   
4.4 Computation of multiple response variables  
Genetic studies, apart from the genetic data of each subject in the study also contain a 
large amount of phenotypical data [4,16,79]. Some common examples are gender, 
race, blood type, height, age at the time the data was collected and also some family 
history data, such as diseases of the subject’s parents, etc. Not all of these may be 
important for analysis but many are. Take gender as an example. It’s well established 
that some diseases even though they occur in both genders, they are more frequent in 
one. This may imply that there are different genetic effects associated with each 
gender. The most common methodologies of analysis of genetic data provide ways to 
either analyze sub-sets of subjects that are expected to have common effects 
independently or combined. In traditional methodologies, this would require running 
the analyses once per response variable. But it’s quite common that many response 
variables are of interest [16]. This has a linear but significant increase in the 
computational cost of the analysis. 
 An innovative methodology involving the use of a 4-dimensional scoring matrix to 
test all of the top results or if needed even of the entire dataset across multiple 
phenotypes with little impact on the computational cost is proposed in this work 
(Figure 9).  The four dimensional matrix is composed of the following dimensions: 
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1. SNP1 genotype 
2. SNP2 genotype 
3. Response Variable Categories 
4. Response Variable 
The example in Figure 9 represents a test between two specific SNPs, the contingency 
tables for the response variables shown underlined and bold are estimated at the same 
time with a single pass through the dataset. Note that the number of categories  
The pseudo code of the implementation of the 4-dimensional scoring matrix is shown 
in Figure 10. 
___________________________________________________________________________ 
 
Figure 9 Contingency tables for two SNPs  and multiple response variables(4d 
representation) 
___________________________________________________________________________ 
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___________________________________________________________________________ 
 
Algorithm: Score4dMatrix 
Input: 
 SNP1 genotypes for all subjects 
 SNP2 genotypes for all subjects 
 Array of response variables for all subjects 
 
Output: 
 4dTable: a four dimensional table with all contingency tables in it scored  
 
Description: This function access all the subjects in the dataset once and scores based on 
the 2 inputted SNPs genotypes each of the contingency tables in the 4d matrix.   
 
 
FOR  all Subjects 
1. //Determine genotypes of SNP1 and SNP2.  
X=SNP1genotype(Subject) 
Y=SNP2genotype(Subject) 
2.  //Loop through each response variable Identify the subject’s category and score appropriate 
cell of contingency table 
For all response variables K. 
Z=ValueofSubjectforReponseVariable(Subject, K); 
4dTable(K,Z,X,Y)++;  
 
Figure 10 Pseudo code of the 4-dimensional algorithm for generating multiple 
contingency tables on a single pass from the database. 
___________________________________________________________________________ 
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4.5 Evaluation of significance through replication 
With the introduction of high throughput genotyping technologies and genome wide 
associations studies, a “blizzard of positive findings” claiming discoveries of 
associations between genetic variants and diseases was reported [76]. However, it 
soon became clear that the majority of these were probably false positives since they 
could not be replicated [27]. Ioannidis et all [29] pointed out that these findings from 
single association studies should constitute “tentative knowledge” and must thus be 
interpreted with exceptional caution.  
In order to verify the reported results of this study and thus the validity of the 
analytical framework proposed, the top results of the analyses in the primary dataset 
will be tested for replication in an independent dataset. Since the number of tests 
performed in the second dataset will be very small, the multiple testing problem 
should not inhibit true positive findings from passing statistical significance.  
Furthermore, replicated results will be examined more closely by looking at the 
distribution of each genotype combination in each dataset to each effect. Results 
where the strongest effect signals exist on the same genotype combinations in both 
studies analyzed will result in significantly more confidence in the replication success. 
To quantify this level of confidence a correlation coefficient will be estimated that 
will represent the level of correlation between each of the effects of the two SNPs. 
This approach will also yield information discovery that will relate each genotype 
combination to disease predisposition.  
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4.6 Hybrid Cluster Cloud High Performance 
Computing (HCC-HPC) 
Two distributed HPC platforms were available for this work. Benchmarking each of 
the HPC platforms resulted in the identification of the bottlenecks associated with 
each HPC, as well as an estimation of the runtime for the given problem for each HPC 
system. The major differences of the two systems are the availability of computational 
processing power, ability to store large amounts of data, and the bandwidth available 
for network communication. 
4.6.1 Dedicated LAN grid  
The first HPC platform was composed of 200 dedicated backend machines in close 
geographical proximity linked together through a high speed Local Area Network 
(LAN), see Figure 11. All machines had access to the same shared storage facility 
through a 1,000 mbps LAN network, and had more than enough space available for 
the needs of this project. For the purposes of this proposal, these resources will be 
referred to as the dedicated LAN grid.  
The dedicated LAN grid is composed of a blade server farm and a front end load 
balancing server. All machines on the dedicated LAN grid have access to the same 
data repository through high-speed connections. All other computers on the network 
can also access the data repository although not at the same high speed as the LAN 
grid. Data in the repository are stored, mirrored and backed-up so there’s no need to 
move it after analysis is complete.   
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___________________________________________________________________________ 
 
Figure 11 Architecture of the dedicated LAN grid 
___________________________________________________________________________ 
4.6.2 WAN grid  
The second computational platform is referred to as the residual Wide Area Network 
grid (WAN grid) and it relies on harnessing residual personal computer cycles to 
create a High Performance Computing (HPC) resource. This resources is implemented 
through the GridMP platform [85,94]. Figure 12 provides a simplified overview of the 
HPC’s architecture.  It is composed of a front end that monitors the available 
computational capacity on several thousand non-dedicated geographically dispersed 
nodes. These nodes are desktop computers concurrently being used by employees at 
the company Glaxo Smith Kline (GSK). The 1500 nodes with the most resources 
available were selected to execute, in the lowest possible priority, work submitted to 
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them by the front end of this grid. The nodes do not share a common data storage 
resource so all data are transferred to the nodes from the front end server and all 
results are transferred back to the front-end server. Since the network bandwidth 
utilized to transfer data between the nodes and the front-end is the same as the one 
used in the day-to-day operations of GSK it is necessary to reduce the load by as much 
as possible so as not to interfere with other potentially critical operations. Also, the 
amount of data storage available on the front-end is limited and shared between all 
applications that utilize the system. Since there is no centralized information of the 
number, schedule or the importance of other operations in GSK that utilize the same 
network strict rules were applied to limit the utilization of the WAN grid to 
applications that do not under any circumstances overload the system.  
___________________________________________________________________________ 
User submitting job
Cloud server, provides 
access to the HPC as a cloud 
service and handles all 
communication and storage 
of the HPC. 
 
Figure 12 Architecture of the WAN grid 
_____________________________________________________________________ 
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The single WAN grid server monitors the available resources of thousands of 
machines around the globe that have an agent running on them responsible for 
reporting to the cloud server. When the WAN grid is requested to perform an analysis 
it selects in real time a subset of the computing nodes with the most available 
resources (processing cycles, main memory) and submits jobs to them. 
Communication is only allowed between each node and the server for security 
reasons.  
4.6.3 Benchmarking of existing HPC resources 
A random subset of the data was selected in order to run a test of the performance of 
the LAN and WAN grids for this specific application (1k, 5k, 10k, 20k SNPs for 1000 
cases and 1000 controls). The algorithm used in this benchmark was the same as in the 
final system and since it’s deterministic, the estimations on the execution time were 
consistent. However, since other users may at any point use either of the systems it 
was essential in order to provide a fair assessment to assume the optimal case where 
no other analyses are running on the systems during the tests. For the LAN grid, a 
high priority queue was used that does not allow any other analyses to take place until 
the benchmarking is complete. In the case of the WAN grid, it was impossible to 
monitor, limit or in any way control the user initiated applications. The cloud server 
did not submit any other work while the tests were running. Due to the high number of 
personal computers that were available in the WAN grid and the fact that the system 
selects only the 1500 (fixed number based on the licenses currently purchased) of 
them with the most available resources to use we expected that the average true 
capacity of the system would be relatively robust. In order to test this, the runtime of 
all analyses performed with the proposed framework where recorded, along with 
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detailed dates and times of the execution. Benchmarking using only the WAN grid 
wasn’t allowed due to the restrictions in data transfer by the operator of the grid, 
therefore execution for that platform can’t be presented. However, it is possible to 
estimate the execution times based on experiments using smaller samples. 
  
4.6.4 HCC-HPC proposed framework 
The residual WAN grid available for this project had significantly larger 
computational capacity available than the LAN grid but limited data transfer and 
storage capacity per. In order to utilize both HPC resources efficiently, a hybrid cloud 
HPC was designed and implemented as shown in Figure 13.  This enabled the 
utilization of the residual WAN grid for the computational needs of the analysis while 
the LAN grid was used to post-process, annotate, merge and query the end results. 
The meta-scheduler breaks up the analysis that needs to be performed into work units. 
Each work unit is responsible for a small number of two SNP interactions. The data 
are split into files each containing the phenotype status and a subset of the SNPs for 
each of the subjects. The analysis is performed by composing each work unit to take 
as input two files, and perform all unordered two SNP combinations in them.  
The maximum number of SNPs (m) in the files is estimated by 
 wm 2  
where w is the number of desired total work units to split the analyses. Having too 
many work units will increase the overhead of the WAN grid, whereas having too few 
will increase the runtime per work unit and therefore increase the frequency of data 
loss occurring from PCs on the WAN grid going offline. The range of acceptable 
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runtimes per work-unit for the system was obtained through trials on the actual system 
using worknodes of various sizes.  
 In order to identify how long a work node would run on average it was tested on a 
typical machine accessible by the WAN grid. Since the algorithm is deterministic, 
these estimations are quite accurate and deviation from them only has to do with 
different load availability on the computational resources. 
 
 
___________________________________________________________________________ 
 
Figure 13 The structure of the purposed built HCC-HPC proposed system 
___________________________________________________________________________ 
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Thresholds for each measure and phenotype are used to identify interesting two SNP 
patterns. Each pattern that passes at least one threshold is reported once by the 
identifiers of the two SNPs. When a work unit has completed the analysis of a 
combination of two input files the results are compressed and transferred to a result 
repository. There, they are accessed directly by the LAN grid to generate the final 
result tables to be used for sorting and creating visualizations of the epistatic and 
omnibus effects based on a-priory defined thresholds. 
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___________________________________________________________________________ 
 
Algorithm:  High level view of Hybrid Cluster-Cloud algorithmic steps 
Input :  
 A GWAS study dataset with all the SNP data and unique subject identifiers 
 The response variables data with subject identifiers to analyse in the entire genome.  
 The response variables data with subject identifiers to analyse for annotation purposes 
on top results 
 The thresholds to use for the first export of top results.  
 A SNP annotation file 
Output : 
 A database with all 2 SNP interaction tests that passed the complete analyses threshold 
in at least one of the measures in any of the response variables analyzed in the entire 
genome.  
 A single result file annotated with SNP information for the results the top results.  
Method 
__________________________________________________________________________________ 
RUNING ON ANALYST’S PERSONAL COMPUTER 
1. //Define data pre-processing parameters 
Define quality control parameters 
Binary Encoding if the data isn’t already encoded 
Define number of segments to split the data into ( w )* 
If data is not in permanent repository, encode and transfer there 
__________________________________________________________________________________ 
RUNNING ON DEDICATED LAN GRID 
2. //Perform pre-processing and initiate analyses on HCC-HPC 
Split data into  w2  segments* 
Initiate Analyses on HCC-HPC 
Wait to receive results from WAN grid 
 
__________________________________________________________________________________ 
RUNING ON WAN GRID SERVER 
3. //Submit worknodes to computational nodes 
For(all submitted worknodes) 
Pseudo code of selection algorithm for PC to use for running a worknode (Figure 15)  
__________________________________________________________________________________ 
RUNING ON WAN GRID NODES 
3   Pseudo code of algorithm followed by the WAN grid agent on each node (Figure 16) 
__________________________________________________________________________________ 
RUNING ON WAN GRID SERVER 
 
4   Pseudo code of WAN grid handling of worknode state reporting (Figure 17)  
__________________________________________________________________________________ 
RUNNING ON DEDICATED LAN GRID 
5   Pseudo code of the LAN grid algorithmic steps (Figure 18)  
__________________________________________________________________________________
  RUN ON ANALYST’S PERSONAL COMPUTER 
6   //Complete analyses transferring results and initiating visualization environment 
Transfer data to analyst’s selected machine 
Launch results query and visualization platform.  
 
 
*w : number of work nodes to be created, system and dataset dependent 
The orange box indicates the part of the algorithmic steps that take place in parallel.  
 
Figure 14 A high level view of HCC-HPC algorithmic steps 
___________________________________________________________________________ 
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In Figure 14 the pseudo code of the algorithmic steps that take place on the HCC-HPC is 
presented detailing the steps in an abstract manner. Different parts of the algorithm are run on 
different machines, as indicated by the break lines. The parts of the algorithm that are run in 
parallel on all machines are highlighted in the orange box. The analysis begins at any personal 
computer that has access to the system. The data is pre-processed then transferred to the data 
repository where it will be permanently stored.  
Once the above step is completed; all necessary data and parameters are stored in the 
permanent storage repository accessible by all machines except the nodes of the WAN grid. 
The web service controlling the Hybrid Cloud-Cluster HPC initiates the analysis on the 
dedicated LAN grid. At step 2the dedicated LAN grid will submit the data to the WAN grid. 
The WAN grid’s architecture required that all data to be used in the analyses resides in a 
temporary area on the grid’s main server thus this step is necessary. In parallel to this step as 
soon as all the data required for a worknode to be instantiated it’s entered into the queue to be 
executed. This is important, since even though the data transfer between the data repository 
and the WAN grid’s server is low, so long as it’s on average faster to transfer the data than to 
analyze them on the WAN grid the total runtime isn’t expected to be affected since the two 
steps are happening in parallel. The analyst from this point on has access to a web service that 
provides all information on the progress of the analyses as well as a detailed record of all 
messages (including errors) that are received.  
The cloud server identifies the 1500 machines on the network with the most available 
resources. The WAN grid performs this step by continuously requesting updates from all 
machines on the network and keeping a list of the top 1500, the list can be considered near 
real time since the machines are only reporting to the server about once every minute. The 
algorithmic steps used to identify the machine to use for analyzing a specific worknode are 
shown in Figure 15. Each machine is looked up to see if it has been used in previous 
analytical iterations with the same data that contained either of the two parts needed for each 
work node. The machine in the list of the ones with the most available resources that already 
has the most data required to run the analyses will be selected and the worknode will be 
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submitted to it. Since data parts are cached (as per the functionality provided by the GridMP 
platform), there is an improvement in efficiency in terms of reducing data transfer as well as 
providing a redundant backup storage location. Once a work node is identified, and all 
relevant data is available on it the analyses is launched on that node in the lowest possible 
priority. 
Algorithm: Selection of PC to use for running a worknode. 
Input :  
Identifier of files needed for the analysis.  
Identifier of worknode 
Output : 
Identifier of PC to be used to analyze the worknode 
 
Identify X machines with most resources available 
 
1   If (among the X machines one has all data parts)  
Submit worknode to machine with all data parts 
2   Else if (among the X machines one has 1 data parts)  
Transfer remaining data part 
Submit worknode  to the selected machine 
3   Else // 
Transfer both data parts to the machine with highest resources available 
Submit worknode to machine 
4   Else 
Submit to worknode with Max Resources both data parts 
Launch worknode analyses on node. 
 
Figure 15 Pseudo code of selection algorithm for PC to use for running a 
worknode 
The WAN grid node that received all the relevant data to analyze a worknode will 
start the analysis as soon as all transfers are complete. The steps followed by the 
WAN grid’s agent on the node are outlined in Figure 16. The agent will perform a 
parity check to verify that the data transferred without errors. Then it will decompress 
all necessary files, and instantiated the analyses wrapped within this agent. This is 
done for security issues and it’s what causes the worknodes inability to communicate 
with any machine other than the WAN grid server. Once the analyses is finished, 
either due to an error or if it’s successful, all outputted files, streams and exit code are 
packaged and send to the grid server.  
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Algorithm: Algorithm followed by the WAN grid agent on each node. 
Input :  
 Location of local repository of all files needed for the analyses 
Identifier of worknode 
Output : 
 All output of the program, including output streams, exit codes and files. 
 
1   A machine receives a worknode to analyze 
Test if data received is not corrupt 
Decompress data 
Run analyses storing stdout and stderr to separate files 
If process crashes, report error and all files generated. 
If process returns, report return code to server along with all the result files produced, 
stdout and stderr files. 
 
 
Figure 16 Pseudo code of algorithm followed by the WAN grid agent on each 
node 
Possible outcomes fall in three categories successful, unsuccessful, error. The algorithmic 
steps followed on the WAN grid to deal with each category are shown in Figure 17. 
Successful worknodes are ones that returned a success completion message to the server and 
transferred all their results to the cloud server with no errors detected. Unsuccessful are work 
nodes that either returned an error code or resulted in an error for more than five times on 
different machines. In the case of returned error codes, each code represents a specific error 
testing criteria, such as errors in the input data; errors found in the analyses step and in general 
if conditions that were predicted to happen and were error tested will return a message to help 
identify the issue. All relevant debugging information is made available through the cloud 
server to the end user. Error worknodes are ones that stopped communicating with the server. 
This could be caused by the work node application crashing or getting killed on the node, or 
the machine might have gone off line. Errors always occur due to the nature of the cloud so 
each work node is run up to five times on different machines before it’s reported as an 
unsuccessful indicating that perhaps there’s something wrong with the program causing the 
crashes. As an example, if a worknode takes too long to run and affects the primary user the 
probability that the primary users on five different machines will either identify it and kill it or 
reboot their machines is high.  
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Algorithm: WAN grid handling of worknode state reporting. 
Input :  
 Identifier of instantiation of a worknode on a specific PC.  
Output : 
 Update of all relevant databases including, overall worknode status reports, and output 
data.  
 
WORKNODE STATE REPORTING 
1   The grid server probes each machine.  
Grid server probes nodes.  
a. If a machine reports worknode completed 
i. Transfer data to cloud server database 
ii. Transfer data to cluster server database 
b. If machine reports worknode error 
i. Transfer all debugging data to cloud server 
ii. Send signal to halt operations on the cluster  
iii. Notify user of reported error.  
c. If machine stops responding. 
i. If worknode last running and incomplete on machine has not crashed more 
than 5 times.  
1. Remove machine from list of machines available.  
2. Mark worknode as not completed and resubmit it. 
3. Increment counter of worknode incomplete.  
ii. Else 5 machines running this worknode became unresponsive. 
1. Attempt to transfer any debugging data available to cloud server 
from all machines.  
2. Send signal to halt operations on the cluster.  
3. Notify user of reported error.  
 
Figure 17 Pseudo code of WAN grid handling of worknode state reporting 
Whenever a worknode is reported to the server as successfully completed the results from it 
are transferred to the permanent storage area on the cluster grid, and the analytical steps on 
lines 3.a.ix and 3.a.x are submitted to run on the cluster. The process on the WAN grid 
finishes when all worknodes get a success or an unsuccessful status. The processes on the 
cluster grid are run in parallel to the grid (Figure 18), beginning as soon as successful results 
become available, but depending on the load of the cluster by other applications completion of 
the steps on this machine might be delayed. Therefore, there might be a short waiting period 
until all worknodes have successfully completed on the cluster as well.  
Execution failures, or data loss are dealt by simply identifying them and reporting them to the 
user. There is an elemental error checking as well as testing return values in a similar way as 
the WAN grid; however there is no need to rerun the worknodes here since errors are very 
rare and usually have to do with something going wrong on the system level, or the worknode 
submitted.  
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Algorithm: LAN grid algorithmic steps. 
Input :  
 Worknode identifier 
 Link to result files on permanent data storage 
Output : 
 Annotated dataset of top results 
 Report on overall execution of system 
 
a. For each new result to complete transfer to the permanent data repository 
iii. Decompress results 
iv. Create first annotated results based on predefined parameters and store in 
the appropriate annotated result database.  
b. Wait for all worknodes to complete on both grids. 
c. If unsuccessful worknodes recorded 
v.  Report to user,  
vi. Break analyses. 
d. Else  
vii. Merge default datasets parts and return them in a user accessible location.  
 
Figure 18 Pseudo code of the LAN grid algorithmic steps 
Once the entire process is completed the first results database is available, along with routines 
to create more result datasets specific to queries performed by the analyst (specific genetic 
regions, top results with specified thresholds, etc)  
4.7 The proposed framework put together 
In this section the entire framework is looked at as well as the steps to take in order to 
evaluate the results it produces and by association the accuracy of the proposed 
framework.  
4.7.1 The analyses on the HCC-HPC 
The proposed framework is provided as a cloud service to all analysts with 
appropriate access. In reality the framework is controlled via a web service. The 
researcher initiating the analysis submits the data to use, if these are not already in the 
permanent storage (if the dataset is new) then it’s automatically transferred there, 
otherwise the existing copy is used. Quality control parameters are defined by the 
researcher and the data is pre-processed. Once this is completed the algorithm of the 
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hybrid cloud-cluster high performance computing system is initiated as described in 
figure 14. During this time, both HPC systems are utilized by the framework, the 
WAN grid running the computational part of each worknode, while the dedicated 
LAN grid as soon as results are delivered from the WAN grid, it decompresses them, 
re-analyzes just the potentially statistically significant ones both with response 
variables used in the primary analyses as well as ones defined as needed to be 
annotated on reported results only and generates the first database of the top results 
fully annotated.  
4.7.2 Post processing results 
The next step is query, visualize, and study the results. The first step is to adjust the 
top results for multiple testing using Bonferoni correction[5,46] and identify any that 
may pass significance after adjustment. Bonferoni correction as it has been stated 
previously is very stringent, meaning that it tends to over-adjust making finding 
statistically significant results very difficult. Also, the statistical power in these studies 
is relatively low due to the relative small number of subjects compared to the number 
of SNPs collected. Therefore it’s quite likely that even results that don’t pass 
statistical significance after Bonferoni adjustment for multiple testing may still be true 
positive effects.  
4.7.3 Replication test 
The first step when evaluating a newly proposed analytical framework is to 
quantifiably demonstrate how likely it is that the results it produces are true positive. 
In genetics, the classic approach for doing this as discussed in previous sections is 
through replication testing with an independent dataset [27,29].  A threshold is set to 
identify the top results with an independent replication dataset. This will both help in 
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discovering more evidence as to whether the top results are true positive or not but in 
extension it will also help validate the proposed framework in its entirety. Discovery 
of strong replicated results will indicate with a high degree of certainty that the 
proposed methodology is capable at detecting true positive effects [4,27,29].  
For the replication test, since the goal of this dissertation is to provide evidence to the 
validity of the framework, only the top results in the dataset used for the primary 
analyses that passed a preset threshold are tested for replication in the independent 
replication dataset, rather than the entire replication dataset. 
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Chapter 5  Results 
This chapter begins with a description of the datasets used to evaluate the proposed 
framework and continues with results generated from the analysis of these datasets. 
Results can be broken into two large categories. The first category refers to the 
Biological results, that relate to the findings of the system in relation to the actual 
analysis performed. The second category refers to the results related to the 
performance of the proposed analytical framework. The biological results are 
presented first, as they lay the foundation of the evidence that the method can produce 
innovative, statistically significant and replicable results. The second part will focus 
on each independent contribution of this dissertation in detail. Experiments were 
carried out to evaluate each of the contributions and the results are presented 
following the biological results in the same order as in the previous chapters.  
5.1 Datasets used for the evaluation of the 
proposed framework 
Two independent datasets were needed that would have the same subject inclusion 
criteria, and overlapping genetic markers genotyped. Two such GWAS were identified 
both designed to study genetic predisposition to Multiple Sclerosis (MS). These are 
presented in the next two subsections along with references to the first publications 
that provide their complete descriptions. 
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5.1.1 Primary dataset (GeneMSA) 
The first dataset was first presented in [80]. The dataset after reported stringent quality 
control data filtering included 551,642 SNPs based on the Sentrix HumanHap550 
BeadChip platform by Illumina (Illumina 550) in 978 MS cases and 883 matching 
controls. Susceptibility, age of onset, disease severity, as well as brain lesion load and 
normalized brain volume from magnetic resonance imaging exams were assessed for 
association with single genetic loci and are presented in [80]. An outline of the 
distribution of subjects and their relevant phenotypes as shown in [80] is presented in 
Table 13. 
The analysis of this dataset revealed 242 statistically significant associations involving 
single SNPs including 65 within the MHC locus [80]. These results were tested for 
replication with another dataset, the IMSGC dataset and confirmed a role for GPC5 
gene in disease risk.  
5.1.2 Replication dataset (ANZgene) 
ANZgene is a three year study that utilized the MS Research Australia (MSRA) Gene 
Bank and involved scanning the DNA of 1,618 people with MS and 3,413 people 
without MS (controls). The genotyping platform used in this GWAS was also made by 
Illumina, but it was the 300k model. ANZgene is a more recent GWAS with the first 
publication expected to be available in print in June 2011 [81]. This dataset will be 
used only to test for replication of the top GeneMSA case-control 2 SNP interaction 
results. The distribution of the phenotypes of interest are shown in Table 14, these are 
the only phenotypes that access was provided to for the ANZgene GWAS.  
105 
 
5.1.3 Addressing incomplete genetic marker overlap between 
primary and replication dataset  
Since ANZgene was genotyped using a different genotyping platform than GeneMSA 
there is not complete overlap between the available SNPs. However the company that 
developed both platforms is the same (Illumina) and it seems that they chose to extend 
the platform used in the ANZgene analyses to create the one used in the GeneMSA 
analyses. Therefore the roughly 300k SNPs in ANZgene seem to exist in the 550k 
SNPs in GeneMSA but obviously there are about 250k SNPs in GeneMSA that are not 
in ANZgene. To test for replication of a two SNP interaction test, it is necessary that 
both SNPs be present in both datasets. This is expected to reduce the number of tests 
possible to test for replication to about 1/3.  
There is an alternative method, sometimes used in genetics when there is a need to test 
for replication between two datasets that were genotyped on different platforms. This 
is called genotype imputation [63,82,83].  However to correctly analyze imputed data 
the probability that the imputed genotype is accurate needs to be taken into account 
[84], something that neither logistic regression nor the proposed methodology for the 
epistasis measure can do. Furthermore, imputation relies on LD between genotyped 
and imputed markers in order to predict each missing genotype with a high level of 
certainty. LD and its effect on the proposed results is one of the key elements of study 
in this dissertation. Relying on a method that is biased based on the level of LD 
between markers may impute markers and might have an undetectable effect on our 
final conclusions. Therefore for the purposes of evaluating the framework imputed 
genotypes will not be utilized.    
  
106 
 
5.2 Biological Results 
The GenMSA analyses resulted in statistically significant results, even after Bonferoni 
correction for multiple testing was applied. The cut-off p-value of 10e-8 was used to 
test for replications in ANZgene. This cut-off was decided a posterior, since it would 
be impossible to correctly define how strong the expected top results would be due to 
the lack of knowledge of the level of dependence between markers and thus the 
inability to correctly adjust for multiple testing. Therefore the cut-off was put at 10e-8 
so that it would include both results that were statistically significant in ANZgene as 
well as those that were high but perhaps lacked the statistical power in GeneMSA to 
reach statistical significance. Since ANZgene and GenMSA were genotyped using 
two different platforms (GeneMSA Illumina 550k, and ANZgene Illumina 300k) in 
order to test for replication of a result it was necessary that both SNPs involved in it 
would be available in the replication dataset. 
In Figure 19, the x-axis represents the ordered location of the two SNPs involved in 
the hypothesis tested; the y-axis represents the epistasis p-value on a negative 
logarithmic scale. Two vertical lines represent the Bonferoni multiple testing 
correction for p-values 0.01 and 0.05. The results where both SNPs are available in 
both datasets are tested for replication and are indicated in Figure 19 as green, if they 
are found to be statistically significant in ANZgene or red if they are not statistically 
significant. Results where one or both of the SNPs were not available for analyses in 
ANZgene are indicated as yellow and replication testing was not performed on them.  
All of the results tested for replication that had both SNPs in or near to the Human 
Leukocyte Antigen system (HLA) region of chromosome 6 replicated successfully, 
while all results outside this region failed to replicate in the replication dataset. 
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The omnibus measure is composed of both the two main effects and the omnibus 
effect. In Figure 20 the omnibus effect (x-axis) is plotted against the Epistasis effect 
(y-axis) both in negative logarithmic order of the resulting p-value. The two vertical 
and horizontal lines represent the p-values of 0.01 and 0.05 following correction for 
multiple testing using Bonferoni correction for each respective measure. By plotting 
the omnibus measure vs the epistasis it is possible to see the relation between the 
epistasis and the two combined main effects since the omnibus measure is composed 
of both the main and epistatic effects.  
Figure 21 has the same properties as Figure 20 but instead of GeneMSA the ANZgene 
replication results are plotted. Here all the tested replications are plotted. The failed 
replications clearly cluster near the origin with very small, if any, effects compared to 
the replication successes that are clearly statistically significant in both omnibus and 
epistasis measures.  
One of the sub-phenotypes analyzed for the top epistasis results is the PRP (a rare 
subtype of MS). Patients with the PRP subtype were tested versus patients with 
Multiple Sclerosis but not PRP. The number of subjects that passed QC and belonged 
to the PRP group was very small, so there was very small statistical power to detect 
effects. In order to limit the search space in an informative way that would improve 
the statistical power of detection after adjusting for multiple testing, only tests that had 
a multiple testing unadjusted p-value of 0.01 in the MS case-control analyses were 
included in this analysis.  
Females are associated with a higher predisposition to MS than males. It is not clear if 
this is due to genetic or environmental factors. In this project we spited the dataset in 
males and females and repeated the case-control analyses with subjects from each 
gender. Since the number of males was only about 1/3 of the total (numbers of males 
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and females) statistical power of detection was significantly higher in females than 
males.  
The parameters of Figure 22 and Figure 23 are the same as in Figure 20. Figure 22 
represents the analyses performed with only male subjects, while Figure 23 represents 
the analyses with only female subjects. Notice that none of the replicated results are 
strong when testing only males, while all of them seem to be driven by females.  
All of the results that replicated involved SNPs that were on chromosome 6. A closer 
look revealed that all of these replicated tests were in or close to the HLA region. 
Figure 24 provides a visualization of the region and the detected epistasis effects. The 
horizontal axis represents the genetic location with base pair position on chr 6 
indicated on the lower horizontal line. Above that line is a gene map of selected genes 
in the region. The horizontal line in the middle of the graph has a short vertical line 
indicating the location of every SNP that was genotyped in GeneMSA. All detected 
epistatic effects in this region that were tested for replication were included in this 
graph and were represented by diagonal lines forming an isosceles triangle connecting 
the two SNPs in each test. The height of the triangle represents the distance between 
the SNPs. The colour represents replicability with red being replication successful 
while blue being replication not possible due to not having both SNPs in ANZgene. 
None of the results in this region that came up in ANZgene and were tested for 
replication failed; therefore there is no colour to indicate replication failure. 
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Figure 19 Top Epistasis results of complete GenMSA case-control analyses. A strong peak is visible were both markers are on 
chromosome 6 in the HLA region some passing statistical significance after multiple testing correction 
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Figure 20 Epistasis vs Omnibus measures of the top Epistasis results in the complete GenMSA case-control analyses  
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Figure 21 Epistasis vs Omnibus measures in ANZgene on the results tested for replication.  
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Figure 22 Epistasis vs Omnibus measures of the top Epistasis results in the analysis of only males in GenMSA 
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Figure 23 Epistasis vs Omnibus measures of the top Epistasis results in the analysis of only females in GenMSA  
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Figure 24 Zoom in of region with high replicated interaction frequency 
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Table 12 GeneMSA dataset description from [80] 3 Distribution of Subj cts in GeneMSA 
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Table 14 Distribution of Subjects in ANZgene 
 
Entire dataset Males Females *Primary Progressive MS *Not Primary Progressive MS 
Cases 1618 445 1173 407 1211 
Controls 1988 757 1231 NA NA 
Total 3606 1202 2404 NA NA 
*Primary progressive is an MS disease subtype. 
NA: Not applicable.  
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Table 15 Results of MS cases vs controls in primary and replication datasets. 
SNP identifiers Annotations SNP1 Annotations SNP2 
Primary Dataset 
(GeneMSA) 
Replication dataset 
dataset (ANZgene) Case Control 
Analyses 
Case Control 
Analyses 
SNP1 SNP2 Gene SNP1 
Chrmosomal 
Position SNP1 
Gene SNP2 
Chrmosomal 
Position SNP2 
Omnibus Epistasis Omnibus Epistasis 
RS3129890 RS9268832 HLA-DRA 06:032522251 
 
06:032535767 29,1 13,1 58 31,69 
RS3130320 RS6457536 
 
06:032331236 C6ORF10 06:032381743 27,6 15,0 56,3 31,55 
RS3130320 RS6935269 
 
06:032331236 C6ORF10 06:032368328 27,7 15,1 55,3 30,94 
RS3115553 RS3130320 
 
06:032353805 
 
06:032331236 27,9 15,3 55,3 30,94 
RS3130320 RS3130340 
 
06:032331236 
 
06:032352605 27,9 15,3 55,3 30,94 
RS3129890 RS7192 HLA-DRA 06:032522251 HLA-DRA 06:032519624 29,1 12,6 57,1 29,76 
RS3096700 RS6935269 
 
06:032329760 C6ORF10 06:032368328 22,2 11,7 48,5 26,38 
RS3096700 RS3115553 
 
06:032329760 
 
06:032353805 22,4 11,9 48,5 26,38 
RS3096700 RS3130340 
 
06:032329760 
 
06:032352605 22,4 11,9 48,5 26,38 
RS3115553 RS3096700 
 
06:032353805 
 
06:032329760 22,4 11,9 48,5 26,38 
RS3130340 RS3096700 
 
06:032352605 
 
06:032329760 22,4 11,9 48,5 26,38 
RS3096700 RS6457536 
 
06:032329760 C6ORF10 06:032381743 22,1 11,4 47,3 24,8 
RS4959089 RS926070 
 
06:032327703 
 
06:032365544 28,6 13,0 54,5 23,8 
RS926070 RS9296015 
 
06:032365544 
 
06:032326967 28,7 12,9 54,5 23,8 
RS3129943 RS3130320 C6ORF10 06:032446673 
 
06:032331236 24,6 11,2 48,3 23,71 
RS2395174 RS9275141 
 
06:032512856 LOC650557 06:032759095 18,6 9,5 48 23,69 
RS3135363 RS6932542 LOC642071, 
LOC642040, 
LOC646668 
06:032497626 
 
06:032488240 20,9 8,0 45,3 21,62 
RS2076537 RS547261 C6ORF10 06:032425613 C6ORF10 06:032390011 20,7 11,0 41,9 20,93 
RS2076537 RS547077 C6ORF10 06:032425613 C6ORF10 06:032397296 20,6 10,9 41,8 20,9 
RS2076537 RS9268132 C6ORF10 06:032425613 
 
06:032362632 21,1 10,8 41,7 20,7 
RS2076537 RS9268368 C6ORF10 06:032425613 C6ORF10 06:032441933 20,6 10,5 41,5 20,62 
RS2076537 RS9268384 C6ORF10 06:032425613 C6ORF10 06:032444564 20,8 10,7 41,5 20,62 
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SNP identifiers Annotations SNP1 Annotations SNP2 
Primary Dataset 
(GeneMSA) 
Replication dataset 
dataset (ANZgene) Case Control 
Analyses 
Case Control 
Analyses 
SNP1 SNP2 Gene SNP1 
Chrmosomal 
Position SNP1 
Gene SNP2 
Chrmosomal 
Position SNP2 
Omnibus Epistasis Omnibus Epistasis 
RS1033500 RS2076537 C6ORF10 06:032415360 C6ORF10 06:032425613 20,9 10,7 41,5 20,62 
RS2076537 RS9405090 C6ORF10 06:032425613 C6ORF10 06:032406350 20,9 10,8 41,5 20,62 
RS9405090 RS2076537 C6ORF10 06:032406350 C6ORF10 06:032425613 20,9 10,8 41,5 20,62 
RS3096700 RS3129943 
 
06:032329760 C6ORF10 06:032446673 20,2 9,0 42,4 20,13 
RS2076537 RS3130320 C6ORF10 06:032425613 
 
06:032331236 30,1 15,5 45,1 18,31 
RS2076537 RS3096700 C6ORF10 06:032425613 
 
06:032329760 25,8 13,4 42,3 17,87 
RS2076537 RS3115573 C6ORF10 06:032425613 
 
06:032326821 18,7 11,4 38 17,22 
RS2076537 RS3130315 C6ORF10 06:032425613 
 
06:032328663 18,7 11,4 38 17,22 
RS3115573 RS2076537 
 
06:032326821 C6ORF10 06:032425613 18,7 11,4 38 17,22 
RS3130315 RS2076537 
 
06:032328663 C6ORF10 06:032425613 18,7 11,4 38 17,22 
RS1077393 RS2242660 BAT3 06:031718508 BAT2 06:031705732 12,9 8,0 33,6 16,65 
RS2076537 RS2239804 C6ORF10 06:032425613 HLA-DRA 06:032519501 17,3 8,4 30,5 15,3 
RS1046089 RS1077393 BAT2 06:031710946 BAT3 06:031718508 13,5 8,1 31,5 14,48 
RS2395150 RS6907322 C6ORF10 06:032434023 C6ORF10 06:032432923 22,4 9,5 40,1 13,99 
RS2395150 RS411326 C6ORF10 06:032434023 
 
06:032319295 23,4 8,2 43,3 13,71 
RS3115573 RS411326 
 
06:032326821 
 
06:032319295 21,4 10,6 34,5 12,82 
RS3130315 RS411326 
 
06:032328663 
 
06:032319295 21,4 10,6 34,5 12,82 
RS411326 RS3115573 
 
06:032319295 
 
06:032326821 21,4 10,6 34,5 12,82 
RS411326 RS3130315 
 
06:032319295 
 
06:032328663 21,4 10,6 34,5 12,82 
RS1053924 RS2269425 PRRT1, 
LOC653870 
06:032228693 LOC653870 06:032231617 18,2 8,9 32 11,2 
RS3129941 RS4959089 C6ORF10 06:032445664 
 
06:032327703 30,3 8,4 51 9,156 
RS3129941 RS9296015 C6ORF10 06:032445664 
 
06:032326967 30,4 8,4 51 9,156 
RS2076537 RS2395150 C6ORF10 06:032425613 C6ORF10 06:032434023 20,0 8,3 35,2 6,65 
RS3115573 RS6907322 
 
06:032326821 C6ORF10 06:032432923 16,8 8,2 22,4 4,116 
RS3130315 RS6907322 
 
06:032328663 C6ORF10 06:032432923 16,8 8,2 22,4 4,116 
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SNP identifiers Annotations SNP1 Annotations SNP2 
Primary Dataset 
(GeneMSA) 
Replication dataset 
dataset (ANZgene) Case Control 
Analyses 
Case Control 
Analyses 
SNP1 SNP2 Gene SNP1 
Chrmosomal 
Position SNP1 
Gene SNP2 
Chrmosomal 
Position SNP2 
Omnibus Epistasis Omnibus Epistasis 
RS6907322 RS3115573 C6ORF10 06:032432923 
 
06:032326821 16,8 8,2 22,4 4,116 
RS6907322 RS3130315 C6ORF10 06:032432923 
 
06:032328663 16,8 8,2 22,4 4,116 
RS3746115 RS761226 MATK 19:003734070 PAK7 20:009769007 6,7 8,0 0,74 1,512 
RS2170239 RS17085 
 
08:014919295 
 
13:047312488 6,8 8,4 1,02 1,319 
RS12705099 RS866482 
 
07:100356394 CADPS 03:062568930 6,5 8,0 1,48 1,119 
RS12705099 RS833632 
 
07:100356394 CADPS 03:062569490 6,7 8,2 1,53 1,094 
RS206789 RS11706107 DEPDC1B 05:059939728 
 
03:074070374 6,7 8,4 0,66 0,954 
RS4326096 RS11706107 
 
05:059926035 
 
03:074070374 6,6 8,3 0,61 0,918 
RS918060 RS1914854 LOC400958 02:065009962 
 
03:111227300 8,0 8,5 0,63 0,773 
RS7527828 RS11909106 WDR64 01:239915670 
 
21:014852044 7,3 8,1 0,34 0,706 
RS555017 RS13235422 MBOAT1 06:020293030 
 
07:017020565 8,3 8,6 0,66 0,646 
RS2268474 RS2059421 TSHR 14:080594160 PLEKHB2 02:131592500 6,8 8,0 0,42 0,568 
RS1202201 RS2165662 MBOAT1 06:020270857 CNTN5 11:099647982 7,3 8,4 0,91 0,512 
RS876594 RS550391 PRMT8 12:003531820 
 
13:068988875 6,9 8,2 0,14 0,402 
RS201247 RS2874146 OFCC1 06:010122547 TRA@ 14:021444239 8,0 8,3 0,25 0,383 
RS1206988 RS2874146 OFCC1 06:010132793 TRA@ 14:021444239 8,1 8,4 0,21 0,354 
RS16945681 RS6139898 
 
18:003926384 CRLS1 20:005962954 7,7 8,0 0,15 0,314 
RS6429288 RS2822767 
 
01:239897499 
 
21:014844910 6,9 8,0 0,05 0,248 
RS6845037 RS2644262 
 
04:182355503 FHOD3 18:032477564 8,1 8,5 0,31 0,193 
RS10909918 RS663003 PRDM16 01:003198235 
 
11:118328358 6,6 8,5 0,13 0,188 
RS6429288 RS11909106 
 
01:239897499 
 
21:014852044 8,0 9,8 0,06 0,181 
RS9894630 RS7889974 SPAG9 17:046526413 
 
X::140992709 9,1 9,7 1,41 0,176 
RS17661532 RS6472762 ANK1 08:041710431 
 
08:074300848 6,6 8,4 0,03 0,17 
RS3750736 RS4238282 OIT3 10:074341617 LOC644725 13:110436314 7,6 9,3 0,02 0,131 
RS9316160 RS368416 
 
13:045210726 
 
15:072301706 6,4 8,3 0,23 0,119 
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SNP identifiers Annotations SNP1 Annotations SNP2 
Primary Dataset 
(GeneMSA) 
Replication dataset 
dataset (ANZgene) Case Control 
Analyses 
Case Control 
Analyses 
SNP1 SNP2 Gene SNP1 
Chrmosomal 
Position SNP1 
Gene SNP2 
Chrmosomal 
Position SNP2 
Omnibus Epistasis Omnibus Epistasis 
RS4238641 RS2029347 
 
16:017629616 KIAA1458 04:048108676 7,2 8,5 0,03 0,096 
RS6877916 RS10490018 
 
05:135269537 TRPM8 02:234582471 9,2 8,2 0,27 0,069 
RS10428541 RS10461060 
 
05:052760915 ATP8A1 04:042242207 6,8 8,6 0,06 0,063 
RS6429288 RS2178933 
 
01:239897499 SAMSN1 21:014831652 6,5 8,2 0,01 0,058 
RS6477190 RS7024902 
 
09:007371520 
 
09:032261795 8,0 8,1 0 0,038 
RS10500737 RS6761029 
 
11:011002835 
 
02:170345142 7,1 8,4 0 0,035 
RS1971156 RS1513536 CNTN5 11:099263024 
 
04:060111325 6,8 8,4 0,82 0,031 
RS1466971 RS9830450 CNTNAP4 16:075056976 ADAMTS9 03:064607296 7,0 8,1 0,01 0,008 
RS2410936 RS4334611 
 
05:106501648 FOXP1 03:071289593 6,8 8,1 0 0,001 
RS10773806 RS9548097 
 
12:129693670 
 
13:037384449 6,7 8,1 0,07 3E-04 
RS1548577 RS5910109 
 
07:019015687 ODZ1 X::123734843 6,4 8,1 0,01 9E-05 
RS4524788 RS4786850 
 
08:084793776 A2BP1 16:006285925 6,8 8,5 0,02 0 
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5.3 Data Encoding 
To evaluate the proposed binary encoding of the data and the PLINK binary encoding 
format the size of the resulting files was considered in relation to the original QTDT 
MERLIN format. Also the amount of information lost through the encoding of the 
original QTDT MERLIN format and the ability of each format to retain different types 
of information available today was computed. Table 16 provides a summary of the 
comparison. 
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Table 16 Results of Data Compression 
QTDR MERLIN Proposed Protocol PLINK ‘s protocol 
Information Loss for bi-allelic markers 
Used as Reference None 
strand location of 
heterozygote alleles 
Aa,aA 
Missing one of the two 
alleles 
A0, 0A, a0,0a 
Added Information capability 
tri or quad allelic 
markers 
Alleles deleted from a 
specific strand 
None 
Size* 
Pedigree File 
3.6 GB 
One binary file 
496 MB 
.bed file : 229.6 MB 
.fam file : 30 KB 
Map File 
12.6 MB 
.bim file : 14.1 MB 
Total:  3.612 GB 
Total : 243.7 MB 
*Using a dataset containing 1804 subjects with 532578 SNPs per subject. 
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5.4 Measure of epistasis 
In order to compare the proposed method for testing for epistasis and testing for 
association allowing for epistasis with the respective logistic regression models, a 
random subset of 218 SNPs were selected from a study that contained half a million 
SNPs and 1868 subjects described in [63]. All pairs of the randomly selected SNPs 
were tested on both methods with omnibus and epistasis as well as the 218 main 
effects. The Pearson’s correlation was then estimated for the main, omnibus and 
epistasis test performed with each approach. The cut-off for the Pearson’s correlation 
is set a-priori for accepting two tests as having a reasonable agreement to r > 0,95 
[47,61].  
An effort was made to keeping all variables that affect runtime for each test constant. 
The same computer was used for all analysis, the analysis were set up to run 
sequentially, while no other program was running on the computer. To make sure the 
implementation of each method was fair, the statistical package R was used to 
implement both methods [61]. R provides all required functions for these tests pre-
implemented and open sourced; all scripts used in the benchmarking of the two 
solutions are also available.  
In order to evaluate the performance of the proposed measures of interaction testing a 
random sample of genetic data was analyzed and the results of the proposed method 
were compared to those of logistic regression. Although both the logistic regression 
and the Pearson’s chi-square test are well established methods for obtaining 
estimations of the main effect of a single marker it is important to compare the two in 
this instance since the chi-square test for the main effect forms the basis for estimating 
the proposed epistasis effect measure between two markers. In Figure 25 a 
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comparison of the main effect estimations is presented. The Pearson’s correlation 
between the two main effect measures is 0.98755. 
The Pearson’s chi-square test performed on a contingency table for 2 SNP genotypes 
is compared in Figure 26 with the omnibus test performed using the logistic regression 
model fitting approach. The Pearson’s correlation for the two omnibus measures is 
0.99287. 
The comparison between the tests of the interaction between the two SNPs for 
association with the categorical phenotype, estimated with the two methods, is 
presented in Figure 27. The Pearson’s correlation for the two epistasis measures is 
0.9616. 
The complete set of all 2 SNP tests (23.6k tests) took 332.5 seconds to run with the 
proposed methodology based on the Pearson’s chi-square test, while the Logistic 
Regression took 6628.37 seconds to run. This constitutes an increase in speed of 
1993% or roughly twenty times faster than the currently commonly used approach of 
logistic regression.  
The two approaches’ results have a reasonable agreement with a correlation 
coefficient greater than 0.95 for each of the main effect, omnibus and epistasis effect 
tests. Non-independence between SNPs can occur due to Linkage Disequilibrium, and 
that will result in wrong results for the epistasis but not the omnibus test since this 
affects the additive property of Pearson’s chi-square. However, well established 
methods exist that can test for LD between markers and therefore detection of false 
positive results because of this issue are minimized.  
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_____________________________________________________________________ 
 
Figure 25 Main effect comparison between logistic regression (y-axis) and 
Pearson’s chi-square test with Yates correction for continuity (x-axis). 
_____________________________________________________________________ 
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_____________________________________________________________________ 
 
Figure 26 Comparison between the omnibus measures produced using the 
Pearson’s chi-square test with Yates correction and the logistic regression model 
fitting test. 
_____________________________________________________________________ 
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___________________________________________________________________________ 
 
Figure 27 Comparison between the Epistasis measures produced using the 
Pearson’s chi-square test with Yates correction and the logistic regression model 
fitting test. 
___________________________________________________________________________ 
 
  
128 
 
 
5.6 Computation of multiple response variables  
Testing the efficiency of the proposed algorithm for computing the multidimensional 
contingency tables involved the analysis of 1, 5 and 10 response variable within the 
same dataset (the primary dataset) was carried out. The variables were all randomly 
generated to match the distribution of the case-control data in the real data. The 
analysis of each group of different phenotypes were run in sequence once using the 
proposed algorithm (Figure 10) and then the sequence was repeated for a total of 3 
times to get the average runtime s. For the traditional approach (Figure 4) [4,50] since 
the analyses is identical when analyzing 5 phenotypes or the first 5 of a total of 10 
phenotypes, in order to reduce the consumption of computational capacity on the 
HCC-HPC the phenotypes were run 3 times generating average runtimes for the first 
1, the first 5 and all 10. The results are shown in Table 17.  
 
Table 17 Performance of proposed contingency multidimensional contingency 
table computing algorithm 
Response variables Proposed algorithm Traditional approach 
1 315min 311min 
5 311min 1584min 
10 320min 3320min 
 All times given in minutes 
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5.7 Evaluation of significance through replication 
The replication test provides two ways to test if the results replicate between two 
independent datasets. The first and more obvious approach is the replication of high 
significance results in both datasets. The second and often overlooked approach is the 
replication of the effects between the different genotype combinations. When testing a 
pair of SNPs for interaction the total number of genotype combinations is nine 
(columns in Figure 9). Each of the effects (omnibus representing the two main effects 
and epistasis, and also the epistatic effect alone) should be distributed in the same 
manner between the two datasets. Figure 28 shows an example of such a test for 
correlation. The graphs represent the odds ratio for each genotype for a specific 
response variable and effect. The X and Y axis represent the main and replicating 
dataset respectively. For a valid replication we expect the majority of the genotype 
combinations, especially the more frequent ones, to be on the x=y diagonal. 
Another way to visualize if a test replicated between two datasets across all genotypes 
with strong associations to disease is shown in Figure 29. In this figure the algorithmic 
steps are followed to estimate the chi square for the omnibus measure between the two 
SNPs as described in section 4.3.1(page 77). In this figure though, in order to get a 
visualization of the distribution of the measure across the genotype combinations for 
each cell  
∑
(         )
 
  
 
 
 
 
The result is a chi square measure of the effect of each column (genotype 
combination). In order to add some more information in the visualization a sign is 
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added to indicate if a genotype combination is more frequent in cases or controls. 
Positive indicates that the genotype combination’s effect is associated with 
predisposition towards having the disease (being a case) while negative with being 
healthy (control). 
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___________________________________________________________________________ 
 
Figure 28 Replication test for correlation of distribution of effects on genotype 
combinations between the two diseases 
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Chi square measure (arbitrary units) per genotype combination sign based on effect direction (cases negative, control positive) 
 
Figure 29 Bar chart of the chi-square metric per genotype in the two datasets signed for phenotype predisposition direction at each 
column. 
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5.8 Hybrid cluster cloud high performance 
computing (HCC-HPC) 
Each HPC system was found to have significant disadvantages [30] that disabled it 
from being used alone for this analysis. Specifically the WAN grid had very limited 
data bandwidth between the nodes and the grid’s server and did not allow for inter-
node communication, while the LAN grid did not have these disadvantages but has 
significantly less computational resources available.  
However, it was found that their advantages and disadvantages were complementary, 
suggesting that utilizing both resources in parallel utilizing a new purpose built load 
balancing algorithm with access to both systems could provide the computational 
capacity necessary to carry out the complete 2 SNP interaction testing of a GWAS 
more efficiently. Existing models of Hybrid Multi-Cloud architectures [85] were 
examined; these did not provide enough control to the developer as to what grid each 
part of the analysis would execute on.  
A benchmarking application was developed that replicates the algorithmic approach of 
this analysis enabling the estimation of the total runtime on each HPC system and 
identifying the bottlenecks that would be encountered if the analysis were to be 
performed on it.   
A feasibility study focused on the computational complexity and statistical power of 
detecting significant gene-gene interactions associated with disease was performed in 
the beginning of this work. The results indicated the need to develop fast algorithmic 
approaches to perform complete analyses of whole genome data producing robust 
statistically accurate measures of the probability that each hypothesis tested is a false 
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positive. The load capacity of the available HPC systems (one relying on load 
balancing clusters, and the other relying on a cloud utilizing desktops simultaneously 
used by their primary users [85]) was tested in order to identify significant bottlenecks 
associated with each [86].  
The results were performed with a 2000 subject dataset (1000 case and 1000 controls) 
and with a datasets with 1k, 5k, 10k and 20k SNPs. The WAN grid server required 
that all results are transferred to the server until the analysis is complete therefore to 
avoid filling up its storage space (only 200GB were available for all projects running 
on it and for both input and output files) all results were deleted after they were 
transferred to the server. This may be a technical limitation, but it’s an important one 
that is worth mentioning since the required analyses required several orders of 
magnitude larger storage capacity that would not be possible under the current 
architecture even if it was to undergo a conservative upgrade. Thus the runtimes 
include the data transfer to the server, but the limitation of the disk size was bypassed. 
The results are shown in Table 18.  
The results in the Table 18 were further expanded to include estimations based on the 
20k SNPs dataset of how long each HPC would take to run in 300k SNPs 550k SNPs 
and 1000k SNPs respectively with the same number of subjects (2000). These 
estimations were computed by taking the 20k SNP datasets runtimes and estimating 
the runtime per work node. Since the computational requirements per worknode 
remain constant (two 1000 SNPs subsets and all 2000 subjects) the only variable that 
changes when the number of markers in the GWAS is increased is the number of 
worknodes. Estimating the number of work nodes each theoretical GWAS dataset 
would generate is done through the steps provided in section 4.6.4. However since 
each HPC system has a different total number of nodes, the estimations reflect the best 
135 
 
 
case scenario for each HPC system assuming all nodes are utilized for performing the 
proposed analysis.  
The results indicated that neither HPC could perform the analyses by itself. The WAN 
grid required a large amount of data to transfer to and from the nodes, as well as to 
store the data on the grid’s main server. Since the machines were spread across a large 
geographical region and were connected through a dedicated private network, the 
impact on performing two SNP interaction testing on the cloud server alone was 
significant to the available networking resources of the network. The majority of 
connections between sites were T1 connections (1.5Mbit upload and 1.5Mbit 
download), with some having T3 (44Mbit) connections. Within each site the majority 
of computers were connected on a 100Mbit LAN network with a few exceptions with 
1000Mbit LAN speed. Since all of these and other machines share these connections, 
and since high priority communications took place constantly throughout the network, 
initiating an analysis that would have had consumed too much of this resource would 
have had an impact on the global operations of the company.  
Thus a preliminary assessment on the amount of data needed was performed. This was 
done by analyzing a randomized sample dataset of 5000 SNPs on the cloud alone. The 
analyses was identical to the one proposed in the HCC-HPC section of chapter 4, with 
the exception that now all results that were returned to the server would be fully 
calculated and annotated. In order to reduce the transfer of data and keep a level field, 
results transferred were limited to those with a p-value for epistasis less than 0.01. The 
result was a file with a size of 1,9 Gbytes. Since the method is deterministic and the 
dataset used had a normal distribution, we can estimate the minimum size needed for 
the 550,000 SNP dataset. That’s 2,30e4 Gbytes, i.e. several orders of magnitude 
higher than the limit of 200GB on the server’s hard drive. It’s important to note that 
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this number only represents the 1% distribution of random top results, in reality true 
positive results will require extra space (although they may not be that many for the 
epistatic effect alone). 
With runtimes for the proposed framework on the 300k, and 550k SNP GWAS 
available it was also possible to estimate the expected system runtime of the proposed 
framework with the current hardware for larger datasets that may become available in 
the future (Figure 30).   
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_____________________________________________________________________ 
 
Figure 30 Estimated runtime based on the number of tests for GWAS up to 3.1 
million SNPs. 
___________________________________________________________________________ 
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Table 18 Experimental and estimated runtime on each HPC and proposed framework. 
Number 
of SNPs 
Number of 
tests 
Number 
of Work 
units 
LAN grid (200 nodes) WAN grid (1500 nodes) Proposed HCC-HPC 
CPU time* System time* 
CPU 
time* 
System 
time* 
CPU time* System time* 
Times derived experimentally with 1000 SNP size work units on a dataset with 1000 case and 100 controls 
1,000 5.00e05 1 3.01 3.01 5.4 5.40 3.5 3.68 
5,000 1.25e07 12 34.9 2.9 65.16 5.43 44.16 3.7 
10,000 5.00e07 50 154 3.00 272.5 5.45 185 3.79 
20,000 2.00e08 200 618 3.09 1092 5.46 727 3.64 
Times Estimated by assuming linear increase with respect to number of tests performed with 20k SNPs test 
300,000 4.50e10 45000 139090 695 179999 164 163.5 109 
550,000 1.51e11 151250 467499 2337 604999 550 549000 366 
1,000,000 5.00e11 500000 1545453 7727 2727270 1818 1818000 1212 
 
* All times are given in minutes. 
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Chapter 6  Discussion 
This chapter begins with a discussion on the biological results generated through the 
use of the proposed framework. Focus is given on the impact of the biological result’s 
replication success with statistically significant results to the confidence of the 
proposed methodology in performing complete 2 SNP interaction testing in GWAS 
datasets. 
The rest of this chapter goes through each of the innovations proposed as part of this 
framework and discusses the results of specific experiments aimed at evaluating the 
performance of each.  
6.1 Biological Results 
The proposed methodology’s results in the analysis of the primary dataset yielded 
statistically significant results even after adjusting for multiple testing. This is a great 
achievement since none of the previously conducted two SNP interaction frameworks 
succeeded in discovering statistically significant results after adjusting for the multiple 
testing problem with the stringent Bonferoni correction.  
Replication testing was conducted on all results that passed the threshold of –log p-
value > 8 in the primary dataset and had both SNPs represented in both datasets. This 
resulted in a total of 84 tests that were repeated in the replication dataset, an 
independent MS study. The a-priory expected number of replications under the null 
hypothesis was that less than 1 (0.84) tests would replicate by chance with the 
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threshold for statistical significance set at a p-value of 0.01. However, a total of 49 
tests were replicated having statistically significant values in the second dataset as 
well. Moreover, nearly all of these tests revealed very strong epistatic effects with 
many orders of magnitude greater than the a-priory defined threshold for statistical 
significance. An even closer look into the distribution of effects on genotypes between 
all of the 49 replicated tests, revealed that the distribution of effects between the 
genotype combinations of each replicated two SNP pair were nearly identical, 
providing further evidence that the replicated results are probably true positive.  
Furthermore, a closer look at the replicated results indicates that they all come from 
within a very specific region commonly referred to as the Human Leukocyte Antigen 
(HLA) region. The HLA region has been considered as a primary suspect for 
immunodeficiency diseases such as MS, with many reported associations across many 
studies[15,80,81] (see Figure 31). 
To summarize the following evidence were found supporting the success of the 
proposed framework: 
(1) Analysis on the primary dataset yielded statistically significant results even 
after Bonferoni correction for multiple testing.  
(2) The top 84 results that were made up of SNPs also genotyped in the 
replication dataset were tested for replication with 49 replicated 
statistically significant results.  
(3) An examination of the distribution of the effect size on each of the 
genotype combinations of the two SNPs revealed matching distributions 
between the two datasets for the replicated, but not for the non-replicated 
results.  
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(4) All the replicated results implicate SNPs in and around a region called 
HLA, known to be associated with MS (see Figure 31).  
The key to note here is that all the above evidence is independent. Thus the probability 
of the combination of the above evidence existing by pure coincidence is highly 
unlikely. This clearly meets all criteria for validation testing of the results 
[29,5,1,54,87]. Comparing to all other methods in the literature that attempted to 
perform two SNP interaction testing, this is the first method based on the literature 
review conducted as part of this work that has provided statistically significant results 
and replication success in an independent dataset [32,54].  
 
 
Figure 31 PubMed search linking Human Leukocyte Antigen to multiple 
sclerosis where 1829 publications were found 
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6.2 Data Encoding  
Compressing data requires a balance between readability, loss of information and 
required reduction in data size. In order to make a decision on how to balance these 
parameters it is important to keep in perspective how the data will be used.  
6.2.1 Information Loss  
On one hand loosing information due to encoding is undesired; however, if the 
encoding is used to simply speed up analyses then it’s not an issue so long as the 
original un-encoded file is kept for future analyses. However if an algorithm that 
needs the information of which strand each heterozygote marker’s alleles are on is 
developed[83], or if there are deletion regions overlapping the markers in either 
strand, then utilizing the encoding methodology proposed in this dissertation will in a 
single table or file encode all of that information efficiently. Another issue is the 
actual storage of the data for long term use or for transferring over the internet. 
Utilizing a non-lossy approach to compressing the data that incorporates all genetic 
information into a single file can reduce the resources required[13,52].   
6.2.2 Added Information Capability  
In this dissertation the focus was on bi-allelic markers as they are the ones that current 
high throughput genotyping technologies are able to genotype. However, it should be 
noted that the format of QTDT Markers enables encoding of tri or quad allelic 
markers as well since each allele is encoded as an ASCII character. Neither PLINK’s 
neither binary ped file nor the format proposed could handle tri or quad allelic 
markers. Large datasets with tri-allelic markers do not exist today (to the knowledge 
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of the author) while information on deleted markers is available through CNV 
analyses and other methodologies available to the various genotyping platforms. Tri-
allelic and quad allelic markers were ignored in this encoding since they are very rare 
and unlikely to be included in GWAS analyses in the future[31,36].  
 
6.2.3 Size of encoded data  
The compression rate can easily be estimated since both encodings are deterministic, 
however an actual test performed using an average dataset size of 1806 subjects and 
532,579 markers is also provide as an example. The PLINK binary ped file was able 
to compress the file to 1/15
th
 of its original size while the proposed method 
compressed the file to exactly double the size of that achieving just 1/7.5
th
 of the 
original size[13,52]. However, both encodings produce enough of a compression to 
overcome the issue of the large data since the data can now fit on the average 
computer’s physical memory (RAM) as today’s typical computer has at least 1 GB 
available[52].   
6.3 Measure of epistasis 
The proposed measures of epistasis and the omnibus measure (testing for association 
allowing for epistasis) were compared to the equivalent logistic regression test. Both 
the correlation between the results, as well as the computing of runtime of each 
approach was evaluated.  First the issue of correlation with logistic regression, the 
traditional analytical approach for this type of analyses is addressed.  
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The a-priori defined threshold for the Pearson’s correlation was passed in the omnibus 
and epistasis measures indicating that there is a reasonably good agreement between 
the two approaches to measuring main, omnibus and epistasis effects.  
An expected problem of the proposed methodology might be caused by non-
independence between markers. This dependence would cause epistasis test results 
estimated relying on the Pearson’s chi-square additive property as described in this 
work to be incorrect. However, well established techniques exist for testing for 
dependence between markers, commonly caused by Linkage Disequilibrium [37]. It’s 
also possible to test for Linkage Disequilibrium in various populations based on other 
datasets that have been fully analyzed and made the results available through the 
HapMap project [36]. The omnibus measure does not utilize the additive property of 
the Pearson’s chi-square test, therefore its validity is not affected by LD [47].  
Runtimes of the two methods were compared, while keeping all other parameters that 
affect runtime of the analyses constant. The proposed Pearson’s chi-square approach 
to estimating epistasis was twenty times faster. This could be translated in savings in 
terms of computational resources needed to perform specific analyses or in the case 
where more tests are needed to be performed than the resources can provide, a 
significant boost by a factor of 20 for the number of possible tests to perform on a 
given computational resource. 
Furthermore, the proposed methodology provides both a measure of interaction 
(epistasis) as well as a measure of association allowing for interaction (omnibus), 
through the analyses of a single contingency table.  
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*MAF= minor allele frequency 
*LD= Linkage Disequilibrium 
 
Table 19 Comparison proposed versus existing measures of epistasis using statistical or data mining approaches 
 
Measures 
Epistasis 
test 
Allow for 
epistasis 
tests 
Response 
variable 
Adjustment 
by 
covariates 
Marker 
type 
Tested on 
real data 
Replicated 
results 
Bias 
Result 
interpretation 
Scalability References 
Proposed 
Method 
Yes Yes Categorical No Genotypic Yes Yes 
Negative on 
LD for 
epistasis 
p-values High [2] 
Regression 
analyses 
Yes Yes 
Categorical
, linear 
Yes 
Genotypic 
Allelic 
Yes Yes 
*LD, in 
some cases 
p-values Low [13,54,55] 
Odds ratio 
Multiplicati
ve 
Interaction 
Yes No Binary No Allelic Yes No 
*LD, 
*MAF, size 
of dataset, 
Heterozygot
e effects 
Approximate
d p-values 
High [3,32,56] 
Case only 
(χ2) 
Yes No Categorical No Genotypic Yes No 
Non linkage 
equilibrium 
p-values, High [13,32] 
Recursive 
Partitioning 
No Yes Categorical No 
Genotypic 
Allelic 
Yes No 
*LD, main 
effects 
None, 
requires 
follow-up 
analyses 
Medium, 
parameter 
dependant 
[32,57,58] 
Multi-
dimensiona
lity 
reduction 
(MDR) 
No Yes Categorical Yes 
Genotypic 
Allelic 
Yes No 
*LD, main 
effects 
None, 
requires 
follow-up 
analyses 
Low [59,60] 
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6.4 Computation of multiple response variables 
In tests performed with the analysis of a single response variable or multiple response 
variables, the expected reduction in runtime was successfully recorded as expected 
(Table 17). The minor deviations between the computational resources available to the 
analyses during each test seem to provide a stronger effect to the runtime than adding 
more than one response variables to test the proposed methodology. However, using 
the traditional approach the computational time of the analysis was consistently 
linearly increased with the addition of each response variable. This result was 
consistent both in terms of the primary analyses of the complete whole genome scan, 
as well as in terms of the annotation stage where response variables were used to 
simply annotate top results from other analyses. Since the algorithm does not attempt 
to estimate but rather attempt to completely compute all contingency tables there’s no 
loss of power associated with this increase in efficiency.  
This algorithm only provides a performance boost when more than one contingency 
table based on the same explanatory variables and different response variables is 
needed. In GWAS associations studies this is the typical case, thus the performance 
increase is valuable since even though linear, it has a pragmatic impact on the runtime 
as it can enable researchers to include a number of the response variables in a single 
analysis run.  
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6.5 Evaluation of significance through replication 
Replication testing is considered the holy grail of verification of reported genetic 
associations to disease [8,27,29,32]. In order to perform a replication test, an 
independent GWAS dataset is needed that has near identical inclusion criteria (same 
disease definition) and the same genetic markers (genotypes). For the purposes of this 
dissertation, the validity of results needs to be determined in order to provide by 
extension the validity of the proposed framework that was used to derive them.  
The replicating dataset had matching subject inclusion criteria, had more subjects, but 
unfortunately it was genotyped on a platform that only included 300k SNPs compared 
to the 550k SNPs in the primary dataset. However, both genotyping platforms were 
generated by the same company (Illumina) and it seems that the 550k platform is in 
fact an extension of the 300k platform. That is the Illumina 550k platform contains all 
300k SNPs from the Illumina 300k platform plus 250k extra SNPs.  
This limited the replication tests to only those that were composed of SNPs genotyped 
in both platforms. However, since the goal of the replication test was primarily to 
provide evidence as to the performance of the proposed framework that is not a 
problem as long as the remaining replicable tests produce successful replications. The 
results with markers not in the replication dataset will be published in order to provide 
the opportunity to researchers conducting new studies to attempt to replicate them in 
future studies of other independent datasets. The threshold of -log p-value >8 was set 
as the threshold for performing replication tests.  
In order to gain further evidence of the replication success between the two datasets, 
two types of figures were generated for all replicated results (Figure 28 and Figure 
29).  
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Figure 28 presents the odds ratio between the two datasets on a specific result plotted 
with each dataset on an axis. We expect that if a result is indeed a true positive then 
the odds ratios of all genotype combinations will be presented across the y=x 
diagonal, as is the case in the example of Figure 28.Figure 29 presents the chi-square 
metric across each genotype combination in each dataset with a sign added to indicate 
if the effect indicated predisposition towards being either a case or a control. It’s clear 
from Figure 29 that the genotype combinations with the strongest effect sizes match in 
both effect size and in predisposition sign between both datasets even though the 
measures used to identify top results and test for replication do not consider the 
distribution of effects across the genotypes. It’s also useful to note that in this graph 
the predisposing genotypes are identified, a key question that needs to be answered as 
a post processing step in all genetic analyses results[8,25] as it can be used to generate 
further hypothesis on the biological mechanisms that form the causality of the 
detected epistatic effect.  
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6.6 Hybrid cluster cloud - high performance 
computing (HCC-HPC) 
6.6.1 Performance of WAN grid alone 
Utilizing the WAN grid alone for this analysis was prohibitive for multiple reasons. 
First, the server that was controlling the entire system only had a 200GB storage space 
and a requirement that all input, output data and debugging data be stored on it for all 
analysis taking place on the WAN grid. That is, not only analyses using this proposed 
framework. The size of the resulting data are several orders of magnitude larger. 
Secondly, the data would need to be transferred to and from the nodes of HPC that are 
scattered around the world and connected through the private network of one of the 
biggest companies in the world, generating that amount of traffic on the network is 
expected to have an impact on the day to day operations of the company and was thus 
prohibited to even try by the IT (Information Technology) administration. Thirdly, 
and perhaps more significant, the results showed, that for large datasets using the 
proposed HCC-HPC platform the runtime was reduced. This is because considerably 
less time was spent waiting for data transfers to complete when using only the WAN 
grid alone.  
6.6.2 Performance of dedicated LAN 
The dedicated LAN performed faster than either the WAN grid or the proposed HCC-
HPC platform but only for very small datasets where the number of work nodes 
created was less than 200. The reason is that it only has 200 processing nodes, while 
the WAN grid had 1500, and by extension the HCC-HPC can utilize both the 1500 
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WAN and the 200 LAN grid simultaneously. When the number of work nodes created 
to analyze a dataset exceeds 200 the analyses on the LAN grid significantly slows 
down since it can only run 200 work nodes in parallel while the WAN grid can 
analyze 1500.  
Considering that the benchmarking was conducted under ideal load conditions for the 
LAN grid given that it was the only application running (tests utilized a special high 
priority queue that suspended all other work on the HPC until all jobs in the priority 
queue finished). The average usage of the system is at around 80%, and genetic 
analyses were considered highly risky exploratory work. So the slots allocated for 
analysis were actually of very low priority, that only ran when no other queues request 
resources.  
6.6.3 Performance of the HCC-HPC proposed platform 
Overall the HCC-HPC performed better than using either HPC alone providing the 
necessary computational resource to perform the complete 2 SNP interaction testing 
framework in a reasonable time. 
The intermediary results coming from the WAN grid that are highly compressed and 
include all results that pass a threshold of p-value < 0.01 in either omnibus or epistatic 
measures in any of the analyzed phenotypes are stored in a permanent storage to 
enable quick future queries testing hypothesis that involve a subset of the search 
space. These are accessible to all machines in the private network equipped with a 
web service that enables query and visualization of all results generated in real time. 
This way, even though the primary 2 SNP interaction analyses was only interested in 
the top results in this case to provide evidence to the effectiveness of the method, in 
the future it’ quite possible that researchers will want to data mine the results buried 
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within the top results to test individual hypothesis they may have. Multiple testing 
only applies to the number of tests a researcher performs, thus if someone were to 
generate a list of tests that he had a-priory defined a hypothesis for, then the multiple 
testing will only apply to the number of tests he will perform, and not to the entire set 
of possible tests performed to generate the dataset. This is assuming of course that 
there was no bias towards the generation of the hypothesis tested by the actual results 
of this analysis.   
The proposed HCC-HPC system has provided the computational requirements needed 
to perform the analyses in a reasonable time frame and considerably faster than using 
either of the two HPC platforms it utilizes individually. However, it is applicable only 
to the problem of testing all pair wise SNPs in a GWAS study for an effect, and even 
though it is an innovative contribution, it’s only a minor one.  
6.7 The proposed framework versus other gene-
gene interaction testing methodologies 
Table 19 provides an overview of the proposed and existing gene-gene interaction 
methodologies. It’s clear that from all tests conducted so far with any methodologies 
the proposed method utilizes the most computational resources. It’s also the only one 
that provides a complete framework for storing all results with a p-value of 0.01 or 
less on any measure and response variable analyzed giving the opportunity to 
researchers to test their future hypothesis without needing to re-run the analyses. 
Furthermore the WAN grid used that provided the majority of the computational 
resources is actually rarely utilised and relies on redundant computing resources on 
personal computers. Thus although it’s a large resource, it’s impact to the cost, and 
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power consumption are minimized since it’s designed to identify machines that are 
already switched on and running (otherwise their resources would had been wasted). 
In doing so, the proposed framework can within a reasonable time span, analyze even 
the largest reported GWAS datasets in existence today (1 million SNPs).  
The proposed method is scalable and provides both a measure of interaction (epistasis) 
and also a measure of the association allowing for interaction (omnibus). It’s the only 
method to have discovered statistically significant results, after Bonferoni correction 
for multiple testing. Also, it’s the only method that has replicated its top findings in an 
independent replication dataset yielding statistically significant results in the second 
replication dataset as well. 
Marchini et al. [54], proposed an exhaustive search for association allowing for 
interaction only on simulated data. The proposed framework presented in this thesis 
dissertation allowed testing for epistasis (epistasis measure)as well as testing for 
association allowing for epistasis (omnibus measure).  
The BOOST [56] and the complementary GBOOST [64] algorithms compute epistasis 
through the use of odds ratios.  Furthermore, even though these algorithms were tested 
on real data, and also tested for replication they did not succeed in generating 
statistically significant results after Bonferoni correction. The replication test although 
it did produce some top results in both datasets, the number of these was not greater 
than what was expected assuming no true positive effects were included in them 
[56,64].  
Recursive Partitioning Tree, and also Random forests techniques [57,58], offer some 
key features, specifically, they enable testing for more than 2 SNP interactions and 
they could also be used to test for interactions between multiple genetic loci, and 
environmental factors. Their key disadvantage though is that they can only be applied 
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to small subsets of data, and not to an exhaustive search of a GWAS. To date, 
statistically significant or replicated results have not been discovered with either 
method [57,58]. 
6.8 Potential pharmaco-genetic impact of the 
proposed framework 
Drugs function by binding and selectively interacting with specific pharmaceutical 
targets. Each drug has its own target(s) that is a protein that it can bind to or interact 
with to modulate its function in a way that inhibits, stimulates or modifies its 
action[88]. With the complete sequencing of the human genome one might expect a 
plethora of drug targets for many diseases to be discovered[7]. This however isn’t the 
case, since the analytical techniques applied to this data were focused on simple 
Mendelian diseases (diseases where a single genetic polymorphism was responsible 
for a phenotypical trait) while the majority of common diseases in humans are 
complex diseases (multiple genetic polymorphisms and environmental factors 
predispose a subject’s disease status)[8].  
The proposed analytical framework attempts to discover evidence of interactions 
between genetic polymorphisms. Thus, looking for epistatic effects, that are closer to 
what is expected to be the underlying causative effect of complex diseases.  
Once statistically significant and replicated results are identified (as is the case in the 
work presented in this dissertation), these can be used to generate new hypothesis that 
can lead to: 
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New drug targets and by extension to new drugs that attempt to inhibit, stimulate or 
modify the action of one or both of the proteins generated by the epistatic effect 
detected[3,32,88]. 
Personalized medicine, by identifying interactions associated with adverse events or 
drug susceptibility, and thus creating the possibility to provide efficient widely 
available genetic tests that will help doctors decide what drug to give to a patient so as 
to increase the likelihood of positive outcome [3,32,79]. 
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Table 20 Two SNP interaction testing frameworks and the proposed method 
Multi-locus 
Interaction 
testing 
framework 
Computing Platform 
HPC 
Scalable 
Measures 
Largest number 
of tests recorded 
Deterministi
c 
Accessibility 
Tested 
on Real 
data 
Replicated 
statistical 
significance 
Refe
renc
es 
Proposed 
method 
Computing cloud of 1500 PC 
nodes, cluster with 200 nodes 
Yes 
Interaction, allowing 
for interaction 
550k SNPs, 
2000 subjcets 
Yes Low Yes Yes  
Exhaustive 
search Marchini 
et al 
10 node cluster Yes 
Association test 
allowing for 
interaction 
300k SNPs 
2000 subjects 
Yes Low No No [54] 
BOOST Single core x86 cpu No 
Odds ratio based 
interaction measure 
351k SNPs 
5000 subjects 
Yes High Yes No [56] 
GBOOST GPU 
Limited 
Scalabilit
y 
Binary odds ratio 
based interaction 
measure 
351k k SNPs 
5000 subjects 
Yes High Yes No [64] 
Recursive 
Partitioning 
(Tree)  
Symmetric multiprocessing 
under development 
No 
Follow up analyses 
necessary to provide 
interpretable measure 
Limited to only 
a few dozen 
SNPs 
Depends on 
parameters. 
High for 
small 
number of 
tests 
Yes No [58] 
Random Forest 
Symmetric multiprocessing, in 
theory HPC compatible with 
many architectures 
No 
Follow up analyses 
necessary to provide 
interpretable measure 
Limited to only 
a few dozen 
SNPs 
No 
High for 
small 
number of 
tests 
Yes No [57] 
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Chapter 7  Conclusions and Future Work 
7.1 Conclusions 
The proposed framework presented in this thesis dissertation looks at all possible pair-
wise interactions between the loci studied, performing an exhaustive search of a 
GWAS dataset. The proposed framework for performing complete two SNP 
interaction test on a GWAS dataset is broken up in the key original contributions of 
this work that had to be developed to address key issues relating to the problem and 
also provide computational efficiencies. Each original contribution performance on 
addressing it’s corresponding problem was evaluated through experiments designed at 
exposing the difference between the proposed approaches and the current approaches 
used in the field as described in the literature.  
The framework, involves first encoding the data in a lossless, binary format that 
significantly reduces its size. The proposed format encodes genotypic data into a 
binary format in order to compress it and at the same time preserve all the information 
relating to the bi-allelic markers and the strand location of each allele. However it 
does double in size the resulting datasets from existing encoding methodologies that 
are lossy, but looses information only necessary to certain type of analytical 
approaches. The analytical approaches that would benefit from the proposed format of 
encoding are primarily the ones that take into account the strand on which 
heterozygote alleles are based on. That is, the existence of the marker on a specific 
DNA strand, identifying if the second wasn’t available due to genotyping errors or a 
deletion over the marker on that strand. Due to the need to use two bits per allele for 
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encoding while only needing 3 states for each allele we were left with an available 
fourth state. That fourth state we proposed that is used to denote markers that were 
deleted as that information is becoming commonly available from genotyping 
platforms available already; however, future researchers may choose to use the fourth 
state to code a different state an allele can be in. Also in cases where compression of 
the data in a non-lossy way for storage, backup or data transfer is needed, the 
methodology proposed would be preferable. 
The proposed frameworks addresses the problem of identifying a measure of epistasis 
and a measure of association allowing for epistasis by proposing a new measure and 
algorithmic approach to estimating it based on Pearson’s chi-square association test 
and it’s additive property. The proposed method, which utilizes the Pearson’s chi-
square to estimate main effects and omnibus tests and uses its additive property to 
estimate the epistasis effect test is twenty times faster than the currently commonly 
used approach of logistic regression. The two approaches’ results have a reasonable 
agreement with a correlation coefficient greater than 0.95 for each of the main effect, 
omnibus and epistasis effect tests. Non-independence between SNPs can occur due to 
LD, and that will result in wrong results for the epistasis test only since this affects the 
additive property of the Pearson’s chi-square test. However this error results in a 
negative bias towards SNP pairs with LD between them. Even though this is not ideal, 
considering all other currently published methods for performing 2 SNP interaction 
most of them exclude SNP pairs that are in LD. Since this problem is not one that 
other methodologies address, the fact that this method only has a negative bias is an 
advantage since it can be looked at as the minimum score of the interaction between 
the two SNPs.  
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In GWAS studies, one key common observation is that more than a single response 
variable is interesting and needs to be analysed. In this dissertation, an algorithmic 
approach was introduced that enabled the analyses of multiple response variables on 
the same explanatory variables with minimal increase in computation time compared 
to analyzing a single variable at a time. The algorithm is based on counting the 
contingency tables, a p-hard problem, simultaneously with a single pass through the 
dataset for explanatory variables rather than a pass for each test.   
The framework presented in this dissertation study addresses the need for a high 
performance computing system capable of performing a test on all possible pair-wise 
interactions between two SNPs through the use of a proposed hybrid cluster-cloud 
high performance computing framework (HCC-HPC).  The combined effect of two 
SNPs on a phenotype can be interpreted in terms of the effect of a single marker’s 
association to the phenotype, commonly referred to as the main effect of the first SNP, 
the main effect of the second SNP, and the interaction between the two, commonly 
referred to as the epistatic effect. The total of these effects is considered as the 
omnibus measure, a term used in statistics to identify tests that are composed by 
multiple independent effects as in this case. The interaction between the two SNPs is 
also considered through a proposed new epistasis measure using logistic regression to 
compare and evaluate the performance of the proposed measure of epistasis.  
The proposed framework is used to perform analyses on GeneMSA, a GWAS with 
multiple sclerosis matching cases and controls that is used as the primary dataset. 
Stringent statistical significance thresholds were defined a-priory adjusted for the 
multiple testing problem. The validity of reported statistically significant results, and 
also of the top results with a p-value less than 10e-8 were tested for replication in an 
independent GWAS called ANZgene. Both the analyses of the main dataset and the 
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replication test of the top results of the main dataset revealed statistically significant 
results after Bonferoni correction for multiple testing. This provides evidence for the 
validity of the replicated statistically significant results, and by extension it also 
provides the evidence that the proposed framework, can discover validated through 
replication statistically significant results. 
7.2 Future Work  
7.2.1 Measure of epistasis for n SNPs 
In the proposed framework SNP pairs were tested for epistatic effects with success. A 
follow up question could be are there any three SNP epistatic effects associated with 
the disease. The search space grows exponentially when increasing the number of 
SNPs in every test, however, filtering, dimensionality reduction and other data mining 
techniques or heuristics could be applied to limit the number of SNPs to test to a small 
subset. However, even though the technology to reduce the search space is available, a 
computationally efficient statistical test to apply in testing for n SNP interaction does 
not. The epistasis measure proposed and accompanied algorithm that also produces 
the omnibus measure can be expanded to test for n SNP interactions. This work is 
ongoing and preliminary results indicate that the performance increase compared to 
applying a logistic regression model is increased even more than the 20 times increase 
in the 2 SNP approach.  
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7.2.2 Distributed Neural Network (NN) approach for subject 
cluster discovery 
Through the application of the two MS dataset to the two SNP analytical framework 
proposed a list of replicated statistically significant 2 SNP interactions were derived. 
These replicated interactions all lie on or very close to a region on chromosome six 
known to be associated with immunodeficiency disorders. This region is in high LD 
and also has many genes in it making it difficult to interpret the results from two SNP 
interactions to two gene interaction effects. The problem then arises on how to further 
analyze the results in the region in order to be able to identify exactly how many 
independent disease factors exists.  
As part of the future work of this dissertation, an analytical work is being designed 
that involves the creation of an efficient distributed Self Organizing Feature Maps 
(SOFM) framework. This framework attempts to cluster the subjects based on the 
genotypes in the region of interest. SOFMs were selected due to their unsupervised 
learning behaviour; this provides a way to test the produced results. If it successfully 
identifies clusters with mostly cases than controls, then we know that the cluster is 
driven by genetic markers associated with the disease.  
This method is already under development, some preliminary results are shown in 
Figure 32. The analysis was run on only cases, only controls and on all subjects, 10 
times. On all runs the largest cluster in both cases and in all subjects seemed to be the 
same involving 42 cases and 9 controls.  
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7.2.3 Gene-gene interaction testing in a box 
One of the key problems of the proposed framework is that it relies on two specific 
HPC resources that belong to a corporation. In doing so, the availability of the system 
is reduced only to that cooperation. In an attempt to provide an alternative that can be 
accessible by any group of researchers new iterations of the proposed framework need 
to be created for different types of computing resources available. A currently 
considered approach is the use of a single server machine with smp x86 processors as 
well as multiple GPU processors. GPU’s have already being applied in performing 
two SNP interaction testing by others (GBOOST program) using alternative analytical 
frameworks [64]. 
The goal is to develop a system prototype based on the compute unified device 
architecture CUDA[65] that utilizes the GPU cores for the analytically intensive part 
and the x86 CPU’s for dealing with annotating, sorting and storing the results. Once 
the system is up and running, estimation on its performance will reveal if it’s a 
direction worth pursuing. The system once completed will be used to provide an open 
analytical platform for analyzing GWAS.  
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Figure 32 Sample run of Neural Network for clustering subjects based on their genetic data at specific loci. 
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